{"meta":{"query_hash":"445f0f0e4493","filters":{"venue":"Therapeutic Advances in Psychopharmacology"},"cohort_total":50,"direct_labels_cover":1,"predictions_cover":50,"exported":50,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/445f0f0e4493","api":"https://metacan.xera.ac/api/v1/cohort?venue=Therapeutic+Advances+in+Psychopharmacology"},"results":[{"id":"W1978878139","doi":"10.1177/2045125312464995","title":"Clozapine treatment of patients with refractory schizophrenia, concurrent dengue infection and hematological abnormalities: three case reports","year":2012,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Clozapine; Dengue fever; Medicine; Neutropenia; Schizophrenia (object-oriented programming); White blood cell; Antipsychotic; Leukopenia; Febrile neutropenia; Pediatrics; Internal medicine; Immunology; Psychiatry; Chemotherapy","score_opus":0.02573286406566617,"score_gpt":0.3629291566811927,"score_spread":0.3371962926155265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978878139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98007005,0.008402945,0.0020333042,0.0024851826,0.00030713045,0.0001981044,0.00013739431,0.00009656338,0.0062692505],"genre_scores_gemma":[0.99503434,0.0023112225,0.0007056986,0.0006969347,0.0003715826,0.00002807605,0.00007565613,0.000014015051,0.0007624926],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99925035,0.00009451926,0.0001333786,0.00012679063,0.00014193813,0.0002529018],"domain_scores_gemma":[0.9985014,0.00029174818,0.000519395,0.00012312994,0.00008805374,0.000476133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035880142,0.0020001982,0.00076882314,0.0021414163,0.0031298986,0.0013800142,0.0010270968,0.0045540943,0.0013288035],"category_scores_gemma":[0.0026650298,0.0012708505,0.0015078383,0.0014634382,0.0019332938,0.0012324824,0.0013620037,0.0027954346,0.0004420931],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037447513,0.000045404362,0.009872595,0.000034511657,0.000019793766,0.9876359,0.00037200752,0.000048577887,0.0004270091,0.00009448924,0.00020194243,0.0012103587],"study_design_scores_gemma":[0.000012262646,0.000049004484,0.004578742,0.000015325546,0.000020593789,0.9943053,0.00018440472,0.000095246956,0.00023047974,0.00005780806,0.0004406536,0.000010265855],"about_ca_topic_score_codex":0.0058585415,"about_ca_topic_score_gemma":0.008169092,"teacher_disagreement_score":0.0058585415,"about_ca_system_score_codex":0.0015098052,"about_ca_system_score_gemma":0.001326225,"threshold_uncertainty_score":0.011648893},"labels":[],"label_agreement":null},{"id":"W2023636483","doi":"10.1177/2045125311433580","title":"Antidepressants, metoprolol and the risk of bradycardia","year":2011,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Pathogenesis and Treatment of Hiccups","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Institute for Clinical Evaluative Sciences; Centre for Addiction and Mental Health; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences","keywords":"Metoprolol; Bradycardia; Medicine; Sertraline; CYP2D6; Odds ratio; Fluvoxamine; Paroxetine; Fluoxetine; Anesthesia; Internal medicine; Population; Confidence interval; Citalopram; Trazodone; Pharmacology; Heart rate; Antidepressant; Serotonin; Cytochrome P450; Blood pressure","score_opus":0.022647915471428203,"score_gpt":0.32926148487582924,"score_spread":0.30661356940440104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023636483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973381,0.0014677768,0.000058124737,0.00012458333,0.000005534938,0.0000040833565,0.00010270164,0.0000024286314,0.0008965305],"genre_scores_gemma":[0.9993673,0.00034930537,0.00005050202,0.000020725613,0.000011880591,0.0000013834789,0.000051868592,5.983592e-7,0.00014646395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997521,0.00006577238,0.000020130808,0.000043845783,0.0000784956,0.00003959357],"domain_scores_gemma":[0.99887615,0.00019263019,0.00064791145,0.000049871236,0.000083922365,0.00014943596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002732544,0.00010167122,0.00015014118,0.00042165912,0.00027177786,0.00043144287,0.00022736116,0.00029481234,0.0010735333],"category_scores_gemma":[0.0018708692,0.00014428435,0.00017176633,0.0004953638,0.0002348508,0.00014463643,0.00016650792,0.00026398577,0.00007180526],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102259706,0.000011109224,0.99763596,0.000007586924,0.000028183438,0.00017462128,0.00002566748,0.000021072941,0.00012959795,0.000017436923,0.00006056405,0.0017858824],"study_design_scores_gemma":[0.0000044010653,0.000021099524,0.9994186,0.000005095495,0.00001271795,0.00027933504,0.00002354446,0.00008852406,0.000021837433,0.00001703045,0.0001067751,0.0000010387025],"about_ca_topic_score_codex":0.03426958,"about_ca_topic_score_gemma":0.052236762,"teacher_disagreement_score":0.03426958,"about_ca_system_score_codex":0.00054539205,"about_ca_system_score_gemma":0.00039203896,"threshold_uncertainty_score":0.06814021},"labels":[],"label_agreement":null},{"id":"W2033679046","doi":"10.1177/2045125312469982","title":"Methadone, QTc interval prolongation and <i>torsade de pointes</i> : Case reports offer the best understanding of this problem","year":2013,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Prolongation; QT interval; Torsades de pointes; Long QT syndrome; Medicine; Methadone; Anesthesia; Intensive care medicine; Internal medicine","score_opus":0.020501855993009133,"score_gpt":0.3358797239266943,"score_spread":0.31537786793368516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033679046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7245068,0.17570102,0.047927324,0.016094161,0.0012944367,0.0002752688,0.00089748984,0.00091322913,0.03239031],"genre_scores_gemma":[0.9667137,0.020037616,0.008225129,0.0018468342,0.0012400524,0.000032607342,0.00017541953,0.000063295556,0.0016654837],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994241,0.00008592425,0.00019409716,0.00012392637,0.00008382478,0.000088135705],"domain_scores_gemma":[0.99364156,0.0026942275,0.0025451717,0.00049101573,0.00038256866,0.00024542626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054168544,0.0008306033,0.00060504605,0.0020541013,0.00072393456,0.0010262346,0.00095313665,0.002490887,0.0025382543],"category_scores_gemma":[0.005075465,0.00048070875,0.00047292543,0.0016627238,0.0011150058,0.003039502,0.00081765576,0.0018851649,0.0010155569],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000642476,0.000044321903,0.086450785,0.00080183265,0.000069401336,0.8616406,0.0016388734,0.0003738666,0.0032827158,0.001991321,0.0026569783,0.0409851],"study_design_scores_gemma":[0.0000035903374,0.000019096591,0.0044614,0.00014758822,0.000029532339,0.98903847,0.00043600475,0.00014906029,0.0009147576,0.000850333,0.0039343475,0.000015740623],"about_ca_topic_score_codex":0.0009399842,"about_ca_topic_score_gemma":0.0011344866,"teacher_disagreement_score":0.0025382543,"about_ca_system_score_codex":0.00038786247,"about_ca_system_score_gemma":0.00042956724,"threshold_uncertainty_score":0.008491337},"labels":[],"label_agreement":null},{"id":"W2035507924","doi":"10.1177/2045125312467348","title":"Sleep architecture in ziprasidone-treated bipolar depression: a pilot study","year":2012,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Sleep and related disorders","field":"Psychology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Pfizer Canada","keywords":"Ziprasidone; Psychology; Placebo; Sleep onset; Rating scale; Polysomnography; Hamd; Psychiatry; Bipolar disorder; Anxiety; Medicine; Insomnia; Mood; Quetiapine; Electroencephalography; Developmental psychology","score_opus":0.02188898218787638,"score_gpt":0.3730288228316048,"score_spread":0.35113984064372844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035507924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99866164,0.00068840897,0.00012423104,0.000024851963,0.000012643969,0.00021686556,0.00005516268,0.000010341164,0.00020580625],"genre_scores_gemma":[0.99853253,0.00050735945,0.00041936513,0.000065394604,0.000051049727,0.0001447541,0.000104398176,0.0000019574584,0.0001732478],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99973255,0.0001236686,0.000027042539,0.000036705005,0.000044079374,0.000035969675],"domain_scores_gemma":[0.99966025,0.00007525068,0.000104324194,0.000032008087,0.000034248675,0.0000940178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007174925,0.00036853238,0.00088964717,0.00017010176,0.00019417408,0.00022784749,0.00026818554,0.00027944823,0.0012261302],"category_scores_gemma":[0.0005821868,0.00016849813,0.00042319213,0.00013329997,0.00027560134,0.00023459212,0.00017229305,0.00051866996,0.00017333875],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3958352,0.04775601,0.051389165,0.001356565,0.0012249263,0.001127517,0.00063811144,0.0011432278,0.25859746,0.000096974574,0.0008222856,0.24001257],"study_design_scores_gemma":[0.06725743,0.7061367,0.21555111,0.000046253863,0.0006977185,0.00081550016,0.00010240537,0.0013691008,0.0065231947,0.00005338083,0.0014211402,0.000026083088],"about_ca_topic_score_codex":0.0008201153,"about_ca_topic_score_gemma":0.0014268279,"teacher_disagreement_score":0.0012261302,"about_ca_system_score_codex":0.00025660684,"about_ca_system_score_gemma":0.00042933144,"threshold_uncertainty_score":0.004101813},"labels":[],"label_agreement":null},{"id":"W2054573828","doi":"10.1177/2045125314553611","title":"Effects of discontinuing anticholinergic treatment on movement disorders, cognition and psychopathology in patients with schizophrenia","year":2014,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Anticholinergic; Psychopathology; Schizophrenia (object-oriented programming); Cognition; Movement disorders; Psychiatry; Biological psychopathology; Psychology; Clinical psychology; Psychosis; Medicine; Anesthesia; Developmental psychopathology; Internal medicine","score_opus":0.005251686283555458,"score_gpt":0.3025257654876059,"score_spread":0.29727407920405047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054573828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987676,0.00081079896,0.000017463632,0.00007481021,0.000008455577,0.000009929555,0.000036084442,0.0000039346583,0.00027085748],"genre_scores_gemma":[0.9992161,0.0004102622,0.0000669771,0.00008135957,0.000021797456,0.000009801112,0.00009560698,0.000001244619,0.00009687928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995122,0.00018894322,0.00006528657,0.00003512534,0.00012873606,0.00006974698],"domain_scores_gemma":[0.9973724,0.0009494071,0.0009771513,0.00008273617,0.0001812523,0.00043706244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011113976,0.00034357456,0.0005878502,0.00022872814,0.00047714903,0.0003328003,0.00016470636,0.00045817878,0.0011051102],"category_scores_gemma":[0.005029745,0.00019400955,0.0006987046,0.00021435588,0.0002327465,0.00027029563,0.00022078227,0.00074914226,0.000118301905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0119875595,0.001727802,0.9153673,0.0002912442,0.00073547085,0.0009541892,0.00094814616,0.00041866838,0.005709601,0.000018602665,0.00046513986,0.0613763],"study_design_scores_gemma":[0.00027609075,0.0056096436,0.9925932,0.000029156115,0.00017812199,0.00041592875,0.00019808921,0.00016552015,0.00021525648,0.0000148628405,0.00029664175,0.000007389755],"about_ca_topic_score_codex":0.0021647955,"about_ca_topic_score_gemma":0.0065679913,"teacher_disagreement_score":0.0021647955,"about_ca_system_score_codex":0.00041095784,"about_ca_system_score_gemma":0.00043550372,"threshold_uncertainty_score":0.005877733},"labels":[],"label_agreement":null},{"id":"W2128652690","doi":"10.1177/2045125313510194","title":"Quetiapine, QTc interval prolongation, and <i>torsade de pointes</i> : a review of case reports","year":2013,"lang":"en","type":"review","venue":"Therapeutic Advances in Psychopharmacology","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"QT interval; Quetiapine; Prolongation; Long QT syndrome; Medicine; Quetiapine Fumarate; Torsades de pointes; Pharmacology; Anesthesia; Cardiology; Psychiatry; Atypical antipsychotic; Schizophrenia (object-oriented programming); Antipsychotic","score_opus":0.019998115906122944,"score_gpt":0.40541266980087926,"score_spread":0.3854145538947563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128652690","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012537924,0.98261166,0.0008187582,0.0008519972,0.00042600182,0.00002269436,0.000071499664,0.0000672993,0.0025921678],"genre_scores_gemma":[0.13794953,0.854348,0.0016987926,0.0017151053,0.0028328048,0.000038510676,0.00022909718,0.000035297147,0.0011528386],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9990036,0.00013194517,0.00035579773,0.00020037896,0.00019773422,0.000110571156],"domain_scores_gemma":[0.99714714,0.0012935736,0.0009624848,0.00015002048,0.00026051296,0.0001862793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054322806,0.0017589829,0.0014930897,0.0076789223,0.0009674739,0.0015235274,0.0021084684,0.00258722,0.0023980425],"category_scores_gemma":[0.0027718921,0.000787392,0.0011274667,0.006327138,0.001528721,0.00304911,0.00096531294,0.0016352657,0.0012654376],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019256753,0.0002139229,0.0347011,0.01425105,0.0006089103,0.6137374,0.0014659024,0.0007101828,0.0030280207,0.0018628605,0.029336462,0.29989165],"study_design_scores_gemma":[0.000013401086,0.00004624131,0.0069481106,0.0020197472,0.0002906714,0.9506662,0.0004243485,0.0001339316,0.00040135725,0.00057477463,0.038440797,0.000040479823],"about_ca_topic_score_codex":0.0021182238,"about_ca_topic_score_gemma":0.0021880348,"teacher_disagreement_score":0.0076789223,"about_ca_system_score_codex":0.0008866413,"about_ca_system_score_gemma":0.0011118932,"threshold_uncertainty_score":0.008022249},"labels":[],"label_agreement":null},{"id":"W2163731432","doi":"10.1177/2045125315583820","title":"Revisiting the ‘self-medication’ hypothesis in light of the new data linking low striatal dopamine to comorbid addictive behavior","year":2015,"lang":"en","type":"review","venue":"Therapeutic Advances in Psychopharmacology","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oakville-Trafalgar Memorial Hospital; Humber River Regional Hospital; University of Toronto","funders":"","keywords":"Addiction; Dopamine; Psychology; Neuroscience; Psychiatry; Addictive behavior; Clinical psychology; Medicine; Cognitive psychology","score_opus":0.1098848747215809,"score_gpt":0.42950422981619557,"score_spread":0.3196193550946147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163731432","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000059669266,0.9986436,0.00007909539,0.00059113716,0.00020058526,0.0000016286391,0.0000074159634,0.000003857572,0.0004129442],"genre_scores_gemma":[0.0004991178,0.9983455,0.00012824069,0.00040989264,0.00027687338,0.0000030708175,0.000015037239,0.0000012033042,0.00032102413],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99980277,0.0000443848,0.00003799548,0.00003477042,0.000062107334,0.00001793823],"domain_scores_gemma":[0.999413,0.00032881615,0.00006333913,0.000015729562,0.00013613507,0.000042846652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008681171,0.00077581225,0.0014472193,0.0028711804,0.00033167965,0.0011482742,0.0010151418,0.0015443916,0.002092948],"category_scores_gemma":[0.0011102596,0.00026098618,0.0005759886,0.002170341,0.000958143,0.0026252312,0.00086025085,0.0026968622,0.0010074218],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061454084,0.0000490548,0.00030799655,0.019085178,0.00012260735,0.00038285597,0.00015386638,0.00028250576,0.0011400037,0.0106874695,0.043916073,0.92381096],"study_design_scores_gemma":[0.000013840393,0.00006185915,0.0016265458,0.006017015,0.00011571224,0.002160633,0.00015248926,0.00012446333,0.00020862199,0.007421881,0.98207194,0.000024805788],"about_ca_topic_score_codex":0.0017817798,"about_ca_topic_score_gemma":0.0035846753,"teacher_disagreement_score":0.0028711804,"about_ca_system_score_codex":0.0009401687,"about_ca_system_score_gemma":0.0016050426,"threshold_uncertainty_score":0.0070016384},"labels":[],"label_agreement":null},{"id":"W2252910702","doi":"10.1177/2045125315612014","title":"Serotonergic antidepressants and increased bleeding risk in patients undergoing breast biopsy","year":2015,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Music Therapy and Health","field":"Psychology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; McGill University; Jewish General Hospital; Concordia University; Hôpital du Sacré-Cœur de Montréal; Sunnybrook Health Science Centre; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; McGill University Health Centre","keywords":"Medicine; Biopsy; Breast biopsy; Odds ratio; Confounding; Internal medicine; Confidence interval; Breast cancer; Surgery; Cancer","score_opus":0.027791447542315995,"score_gpt":0.37327870934743473,"score_spread":0.34548726180511874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2252910702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99912435,0.0005027797,0.000055497418,0.00002516544,0.000003320297,0.000003941394,0.00009384452,0.0000023781652,0.0001886474],"genre_scores_gemma":[0.9995726,0.0001740237,0.000072626106,0.00001248625,0.000009451435,0.0000020459743,0.000109200555,6.724976e-7,0.000046913217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995122,0.00012931958,0.00007636414,0.000081998674,0.00013220373,0.000067813264],"domain_scores_gemma":[0.99740905,0.00050814514,0.001608547,0.00010506814,0.00016356404,0.0002055779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004915019,0.00018321106,0.00028963902,0.00071165676,0.00025738406,0.00040505468,0.00023960073,0.0003345483,0.0014123996],"category_scores_gemma":[0.0032610432,0.00019411059,0.00031951873,0.00078416325,0.00020392277,0.00020484121,0.00023967201,0.000424006,0.00017610421],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008226684,0.000007609313,0.99915063,0.0000045836123,0.00001636598,0.00006626681,0.000012010019,0.000007257742,0.00008773008,0.000002804831,0.000017848128,0.00054457836],"study_design_scores_gemma":[0.00000578261,0.00006656977,0.9988564,0.000005225179,0.000019312462,0.0008004376,0.00004324934,0.000087871435,0.000049272232,0.000005546659,0.000058492024,0.0000017988535],"about_ca_topic_score_codex":0.003479993,"about_ca_topic_score_gemma":0.003952091,"teacher_disagreement_score":0.003479993,"about_ca_system_score_codex":0.00021603736,"about_ca_system_score_gemma":0.00019917439,"threshold_uncertainty_score":0.0069194436},"labels":[],"label_agreement":null},{"id":"W2314877083","doi":"10.1177/2045125316637570","title":"Multiple D2 heteroreceptor complexes: new targets for treatment of schizophrenia","year":2016,"lang":"en","type":"review","venue":"Therapeutic Advances in Psychopharmacology","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Dopamine receptor D2; Neuroscience; Metabotropic glutamate receptor 5; G protein-coupled receptor; Agonist; Chemistry; Metabotropic receptor; Metabotropic glutamate receptor; Dopamine; Biology; Receptor; Signal transduction; Cell biology; Biochemistry","score_opus":0.041021159629292606,"score_gpt":0.3933467705085898,"score_spread":0.3523256108792972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314877083","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.063578404,0.9061168,0.005741125,0.0077132084,0.0014304548,0.00018527894,0.00092464185,0.00036604886,0.013944111],"genre_scores_gemma":[0.23247698,0.7328433,0.007868276,0.0056482726,0.0009759303,0.00026737442,0.0012636175,0.00007124968,0.018585041],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99991083,0.00002124876,0.0000075504963,0.00001251862,0.000028371247,0.000019568404],"domain_scores_gemma":[0.9999354,0.000009529604,0.000016030059,0.0000032942694,0.00001804399,0.000017766362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026217906,0.00034051342,0.00061155064,0.0005341272,0.00017193412,0.0004993106,0.00041756072,0.000430513,0.0059462525],"category_scores_gemma":[0.00018720923,0.000105118976,0.00050773454,0.00027958545,0.00024189218,0.00040260036,0.00040311422,0.0016808,0.0011034781],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023856633,0.0011521587,0.0010871214,0.0040162182,0.00039497786,0.0010116356,0.00020810914,0.001141204,0.08085608,0.014488145,0.033677835,0.85958093],"study_design_scores_gemma":[0.0028200084,0.0060346466,0.01104122,0.0018429623,0.0005668374,0.0025470674,0.00039624423,0.0020797988,0.02218865,0.015131969,0.935228,0.0001225859],"about_ca_topic_score_codex":0.0008010887,"about_ca_topic_score_gemma":0.0035512317,"teacher_disagreement_score":0.0059462525,"about_ca_system_score_codex":0.00040144444,"about_ca_system_score_gemma":0.00034400568,"threshold_uncertainty_score":0.019892156},"labels":[],"label_agreement":null},{"id":"W2335555764","doi":"10.1177/2045125314542098","title":"A qualitative study of the attitudes of patients in an early intervention service towards antipsychotic long-acting injections","year":2014,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Antipsychotic; Medicine; Psychiatry; Intervention (counseling); Focus group; Qualitative research; Psychoeducation; Clinical psychology; Family medicine; Schizophrenia (object-oriented programming)","score_opus":0.05076891007372378,"score_gpt":0.47894867056198775,"score_spread":0.428179760488264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335555764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99149793,0.00047416068,0.0011810956,0.0029539813,0.0000866202,0.0001898712,0.00010741842,0.000014982631,0.0034939],"genre_scores_gemma":[0.9952571,0.0005900063,0.00067076355,0.0011573094,0.000028038368,0.00022325109,0.00004897254,0.000016317399,0.002008241],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9890577,0.008127498,0.0002724079,0.0003730196,0.00058923545,0.0015801409],"domain_scores_gemma":[0.9735589,0.01883315,0.0017987012,0.00039853447,0.0018977447,0.0035129967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012382286,0.0006242546,0.00092000194,0.0012587635,0.009159806,0.0039968523,0.0017222795,0.00184402,0.0040684873],"category_scores_gemma":[0.01920329,0.00071195466,0.000542947,0.0014730021,0.008288811,0.0036316137,0.004190392,0.0039640167,0.00046295606],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006242148,0.000080304795,0.0034195804,0.00011659211,0.0000041576777,0.00068998744,0.99226964,0.00002190772,0.00039779735,0.00043601292,0.00034583535,0.0021557112],"study_design_scores_gemma":[0.000007763498,0.00008853768,0.0013058748,0.00009747722,0.000002882321,0.00016187411,0.99513054,0.00004064796,0.00009426225,0.000091047856,0.002969946,0.00000913923],"about_ca_topic_score_codex":0.0094946865,"about_ca_topic_score_gemma":0.013471647,"teacher_disagreement_score":0.012382286,"about_ca_system_score_codex":0.0065512215,"about_ca_system_score_gemma":0.0065121995,"threshold_uncertainty_score":0.06548458},"labels":[],"label_agreement":null},{"id":"W2346815948","doi":"10.1177/2045125316643674","title":"A randomized, double-blind, cross-over, phase IV trial of oros-methylphenidate (CONCERTA <sup>®</sup> ) and generic novo-methylphenidate ER-C (NOVO-generic)","year":2016,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Lakehead University; Adler; University of Toronto; START Clinic","funders":"","keywords":"Methylphenidate; Attention deficit hyperactivity disorder; Randomized controlled trial; Medicine; Psychiatry; Psychology; Pediatrics; Internal medicine","score_opus":0.07538036676127366,"score_gpt":0.4452671212700739,"score_spread":0.36988675450880026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346815948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96209365,0.0022654373,0.0012896777,0.0006643806,0.001172943,0.027462104,0.0015886545,0.00036692104,0.003096226],"genre_scores_gemma":[0.9355212,0.0026045858,0.005905543,0.0015660471,0.0008527322,0.04358168,0.0016153959,0.00007267136,0.00828016],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990835,0.00035874711,0.00006000371,0.00024487198,0.0000831059,0.0001696638],"domain_scores_gemma":[0.9985721,0.00034528403,0.00028147502,0.00014250453,0.00014162336,0.00051687605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018457589,0.0030432786,0.004265807,0.0006624098,0.00069876626,0.0011675329,0.001912703,0.0027612795,0.007775267],"category_scores_gemma":[0.0020677694,0.0015012859,0.0012524924,0.0004831886,0.0020768999,0.001526098,0.0005692082,0.0035430726,0.0018459231],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95900387,0.026727524,0.00020110351,0.00039393763,0.00025609945,0.000020437497,0.000050765,0.00019020044,0.0037152495,0.000111178386,0.00057158276,0.008758123],"study_design_scores_gemma":[0.9463363,0.052444458,0.00033323633,0.000012497111,0.000065472006,0.000009096318,0.000008351064,0.0001783654,0.0002645625,0.0000619337,0.00027851367,0.0000072237635],"about_ca_topic_score_codex":0.0011670353,"about_ca_topic_score_gemma":0.0023984073,"teacher_disagreement_score":0.007775267,"about_ca_system_score_codex":0.00092035346,"about_ca_system_score_gemma":0.0022396925,"threshold_uncertainty_score":0.026010871},"labels":[],"label_agreement":null},{"id":"W2416276489","doi":"10.1177/2045125315583819","title":"Association of quetiapine with ischemic brain stem stroke: a case report and discussion","year":2015,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quetiapine; Olanzapine; Risperidone; Medicine; Food and drug administration; Psychiatry; Atypical antipsychotic; Adverse effect; Clinical trial; Schizophrenia (object-oriented programming); Antipsychotic; Internal medicine; Pharmacology","score_opus":0.024130165184784353,"score_gpt":0.3799477712307354,"score_spread":0.3558176060459511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416276489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.891873,0.02818261,0.010114762,0.032729175,0.0027280417,0.00048510334,0.000705325,0.0006312037,0.032550834],"genre_scores_gemma":[0.96993524,0.009815021,0.00320325,0.005421882,0.0066399695,0.000068314686,0.00023860594,0.000054897635,0.0046228026],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9989164,0.0001226997,0.0001378645,0.00032055803,0.0001636763,0.00033871885],"domain_scores_gemma":[0.9983639,0.00048481437,0.00039803807,0.00014223508,0.000110870445,0.0005001225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052582036,0.0025273834,0.001548038,0.004957407,0.004701591,0.0025714647,0.0025519512,0.012431492,0.004130538],"category_scores_gemma":[0.0029839734,0.0012913444,0.0021585894,0.0035375599,0.002666323,0.0043197796,0.002866743,0.0068577905,0.0013312858],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010433609,0.000031948373,0.001542478,0.00001554366,0.0000060118596,0.9970592,0.0001329911,0.000038390517,0.00014094551,0.00016860027,0.00023982523,0.0006137084],"study_design_scores_gemma":[0.0000044553562,0.000018534372,0.0009597252,0.000011866104,0.000010432219,0.9980878,0.00012439443,0.00010234759,0.00010025215,0.0001973541,0.00037320718,0.000009647985],"about_ca_topic_score_codex":0.0052072555,"about_ca_topic_score_gemma":0.0054058875,"teacher_disagreement_score":0.012431492,"about_ca_system_score_codex":0.0021121115,"about_ca_system_score_gemma":0.0014375048,"threshold_uncertainty_score":0.015324473},"labels":[],"label_agreement":null},{"id":"W2465754974","doi":"10.1177/2045125316656297","title":"Overcoming functional impairment in postpartum depressed or anxious women: a pilot trial of desvenlafaxine with flexible dosing","year":2016,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; B.C. Women's Hospital & Health Centre","funders":"Pennsylvania State University","keywords":"Dosing; Medicine; Psychiatry; Functional impairment; Clinical trial; Psychology; Clinical psychology; Pharmacology; Internal medicine","score_opus":0.03278728250040058,"score_gpt":0.3609094739980007,"score_spread":0.32812219149760014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2465754974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986229,0.00031805426,0.00009197585,0.00007767401,0.000028981922,0.0005873706,0.000075265205,0.000011455572,0.00018644989],"genre_scores_gemma":[0.99720913,0.0004613988,0.0005438787,0.00016330792,0.000056923276,0.0010379741,0.0001513131,0.0000030433564,0.0003729926],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994974,0.000253254,0.00005206179,0.000059819464,0.00003079057,0.00010666261],"domain_scores_gemma":[0.9992861,0.0002499491,0.000117142525,0.000070054746,0.000035483266,0.00024129378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016857169,0.00085365435,0.0012847204,0.00034167123,0.0004196667,0.00050082756,0.00091625605,0.0010337554,0.001845691],"category_scores_gemma":[0.0015118279,0.00050263415,0.0010779969,0.00030754716,0.0009904872,0.0005530184,0.00036909984,0.0016580684,0.00027484927],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86613184,0.063407175,0.0055861063,0.00048518655,0.0007840067,0.00028159338,0.0004362373,0.00054018846,0.00930003,0.00007054398,0.00031973718,0.052657347],"study_design_scores_gemma":[0.36443123,0.62086266,0.012887399,0.000025043093,0.00020928818,0.0000875009,0.00011071227,0.00039929122,0.0006595013,0.000044531967,0.0002672647,0.000015581407],"about_ca_topic_score_codex":0.0018077622,"about_ca_topic_score_gemma":0.0030520975,"teacher_disagreement_score":0.001845691,"about_ca_system_score_codex":0.0005893759,"about_ca_system_score_gemma":0.00083969237,"threshold_uncertainty_score":0.008915067},"labels":[],"label_agreement":null},{"id":"W2545937586","doi":"10.1177/2045125316675579","title":"Lactate in the brain: an update on its relevance to brain energy, neurons, glia and panic disorder","year":2016,"lang":"en","type":"review","venue":"Therapeutic Advances in Psychopharmacology","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; University of Alberta","keywords":"Neuroscience; Astrocyte; Brain function; Biology; Tiagabine; Neuron; Metabolomics; Central nervous system; Bioinformatics; Epilepsy; Anticonvulsant","score_opus":0.08669559641516016,"score_gpt":0.4679092021489538,"score_spread":0.38121360573379365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545937586","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006910532,0.99885535,0.00004203567,0.00029780206,0.00032397063,0.0000020871362,0.000012725993,0.000003160083,0.0003936581],"genre_scores_gemma":[0.00033404352,0.99860567,0.00008969592,0.00018944438,0.00042315366,0.0000030878568,0.000020864185,0.0000010585414,0.00033305518],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981683,0.000031801253,0.00004441316,0.000028727243,0.000061052146,0.000017235549],"domain_scores_gemma":[0.99965286,0.00017212298,0.00005010703,0.0000078636795,0.000082140934,0.000034992925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005579593,0.0010045695,0.0016074422,0.0028780086,0.00033966365,0.0013331764,0.00079133053,0.0013225873,0.003545144],"category_scores_gemma":[0.00075200835,0.00030600757,0.0006368831,0.0027490794,0.00056042575,0.0019462947,0.0009414267,0.0020041391,0.0016601945],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010362735,0.00007201885,0.00025394864,0.023427267,0.000113083384,0.0005405611,0.00017077214,0.00024987877,0.0012231183,0.0034583982,0.062441718,0.9079456],"study_design_scores_gemma":[0.000015569967,0.00009888426,0.0010033523,0.0064356844,0.00014035171,0.0029477822,0.00012554211,0.00006574183,0.00018585694,0.0019533,0.9870018,0.000026100863],"about_ca_topic_score_codex":0.0013246547,"about_ca_topic_score_gemma":0.002595823,"teacher_disagreement_score":0.003545144,"about_ca_system_score_codex":0.00061392435,"about_ca_system_score_gemma":0.0011061187,"threshold_uncertainty_score":0.011859655},"labels":[],"label_agreement":null},{"id":"W2606057241","doi":"10.1177/2045125316681985","title":"Results of lumbar puncture, CT and MRI in a case of quinacrine-induced psychosis involving a patient with cutaneous lupus erythematosus","year":2016,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Ion channel regulation and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Lumbar puncture; Psychosis; Cutaneous Lupus Erythematosus; Systemic lupus erythematosus; Dermatology; Lupus erythematosus; Psychiatry; Pathology; Immunology; Cerebrospinal fluid; Disease","score_opus":0.01047871869527927,"score_gpt":0.29626315258669933,"score_spread":0.28578443389142005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606057241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842801,0.0023987617,0.0011681025,0.0019817566,0.00012450083,0.000100797806,0.00030756535,0.00011132842,0.009527002],"genre_scores_gemma":[0.9976726,0.0006252838,0.00030419242,0.00051034964,0.00018320419,0.00000822005,0.00007221675,0.000015373313,0.00060858927],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996147,0.000045481695,0.000056485333,0.00008326452,0.00005709576,0.00014292717],"domain_scores_gemma":[0.998982,0.00032531333,0.00015233539,0.00007485897,0.0000907111,0.00037474558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019497926,0.0012625969,0.00075365085,0.0017721293,0.0017435646,0.0009633743,0.0011556597,0.0042032455,0.001802202],"category_scores_gemma":[0.0023370862,0.0010911495,0.0010367765,0.0008476271,0.001604032,0.000991114,0.00088113506,0.001999885,0.00074523565],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110029716,0.00004865758,0.0069973436,0.00002350516,0.00000926032,0.990816,0.00018565646,0.00006692964,0.0010336182,0.00003545648,0.00009250915,0.0005810458],"study_design_scores_gemma":[0.000032572647,0.00020198975,0.020332448,0.000019652278,0.00005153793,0.9770114,0.00026322133,0.00036808127,0.0011774962,0.00013792685,0.00037585484,0.000027837223],"about_ca_topic_score_codex":0.0060369405,"about_ca_topic_score_gemma":0.0036181908,"teacher_disagreement_score":0.0060369405,"about_ca_system_score_codex":0.001167742,"about_ca_system_score_gemma":0.0006758425,"threshold_uncertainty_score":0.012003601},"labels":[],"label_agreement":null},{"id":"W2740267574","doi":"10.1177/2045125317720642","title":"Assessment and management of sexual dysfunction in the context of depression","year":2017,"lang":"en","type":"review","venue":"Therapeutic Advances in Psychopharmacology","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Translational Research in Oncology","funders":"","keywords":"Sexual dysfunction; Nefazodone; Context (archaeology); Trazodone; Depression (economics); Agomelatine; Medicine; Psychiatry; Moclobemide; Bupropion; Escitalopram; Vortioxetine; Clinical psychology; Psychology; Antidepressant; Major depressive disorder; Mood; Internal medicine; Fluoxetine; Anxiety","score_opus":0.12988760766198174,"score_gpt":0.5088671939754214,"score_spread":0.37897958631343964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740267574","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000095624244,0.9994671,0.000030254438,0.00011591863,0.000037093017,0.000005347636,0.000009242477,0.0000014372145,0.00023800545],"genre_scores_gemma":[0.0010787959,0.99855477,0.00012408572,0.000093779934,0.000050494415,0.0000071761865,0.000015318647,5.0163044e-7,0.000075122894],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995608,0.00014450557,0.00011143685,0.000043211872,0.00011460969,0.000025432157],"domain_scores_gemma":[0.99921334,0.0005147417,0.0001304407,0.000014695811,0.00010349536,0.00002323188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000939844,0.0006116235,0.0014353025,0.0023274103,0.0002740601,0.0009250177,0.00084485894,0.00092495343,0.0023475306],"category_scores_gemma":[0.0023140283,0.00022684754,0.0009165185,0.0017074009,0.00038403663,0.00081451534,0.00054927054,0.0010904253,0.0004169476],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098407734,0.000055897144,0.00046837714,0.072403885,0.0003688429,0.0002025825,0.000109636014,0.00022176081,0.00028664226,0.0010504866,0.010932483,0.91380095],"study_design_scores_gemma":[0.00017555495,0.0003137438,0.010366706,0.15582967,0.0025048174,0.0077010323,0.00063470745,0.00038925992,0.0006846575,0.0034117112,0.81792617,0.000061926454],"about_ca_topic_score_codex":0.0022954817,"about_ca_topic_score_gemma":0.0047296463,"teacher_disagreement_score":0.0023475306,"about_ca_system_score_codex":0.0005584083,"about_ca_system_score_gemma":0.0014688169,"threshold_uncertainty_score":0.00785327},"labels":[],"label_agreement":null},{"id":"W2772327035","doi":"10.1177/2045125317743435","title":"Neuromodulation for the treatment of eating disorders and obesity","year":2017,"lang":"en","type":"review","venue":"Therapeutic Advances in Psychopharmacology","topic":"Eating Disorders and Behaviors","field":"Psychology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Eating disorders; Neuromodulation; Deep brain stimulation; Obesity; Medicine; Anorexia nervosa; Quality of life (healthcare); Transcranial direct-current stimulation; Anorexia; Psychiatry; Clinical trial; Management of obesity; Psychology; Psychotherapist; Weight loss; Disease; Stimulation; Internal medicine; Parkinson's disease","score_opus":0.11089715980295663,"score_gpt":0.49790926147163866,"score_spread":0.38701210166868205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772327035","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014314974,0.99830914,0.00011794091,0.00021498607,0.00014378801,0.000006483874,0.000015041653,0.000007433791,0.0010421132],"genre_scores_gemma":[0.0007948408,0.9981635,0.00018652734,0.0001484146,0.00012465875,0.0000074644313,0.000019784706,0.0000014979677,0.0005532539],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985003,0.000027186965,0.000026773128,0.000023233917,0.000058981354,0.000013649049],"domain_scores_gemma":[0.99980885,0.00010769523,0.000028789407,0.00000547974,0.00003491997,0.00001428953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003749391,0.000609316,0.0008345824,0.0016785549,0.00022278183,0.00067734945,0.0005477473,0.0008389322,0.004780315],"category_scores_gemma":[0.0005755254,0.00013355061,0.0005099132,0.0011168986,0.00033752975,0.0007217364,0.0006006918,0.0016334265,0.0017992097],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057495803,0.00008840754,0.00011491065,0.013928616,0.000081320904,0.00014582794,0.000049701557,0.00017440374,0.0015039275,0.0021447395,0.013666111,0.9680445],"study_design_scores_gemma":[0.000036709043,0.000155118,0.0015541357,0.008903992,0.00019845176,0.002691749,0.00008807957,0.00013606052,0.0007776027,0.0032617305,0.9821716,0.000024764455],"about_ca_topic_score_codex":0.00072183687,"about_ca_topic_score_gemma":0.0015797,"teacher_disagreement_score":0.004780315,"about_ca_system_score_codex":0.00032074962,"about_ca_system_score_gemma":0.0006947592,"threshold_uncertainty_score":0.015991747},"labels":[],"label_agreement":null},{"id":"W2775071978","doi":"10.1177/2045125317743651","title":"Benzodiazepine prescription in Ontario residents aged 65 and over: a population-based study from 1998 to 2013","year":2017,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Sleep and related disorders","field":"Psychology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Institute for Clinical Evaluative Sciences; Centre for Addiction and Mental Health","funders":"","keywords":"Medical prescription; Lorazepam; Medicine; Benzodiazepine; Zopiclone; Population; Anxiety; Demography; Psychiatry; Insomnia; Environmental health; Internal medicine; Pharmacology","score_opus":0.023279324485372923,"score_gpt":0.3756775451712986,"score_spread":0.3523982206859257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775071978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98478866,0.0008718583,0.00013575247,0.0004984829,0.000017076702,0.00008343727,0.0117753865,0.000014174888,0.0018153179],"genre_scores_gemma":[0.9936506,0.0007523097,0.0002042573,0.000262643,0.000019548343,0.00006941668,0.004098836,0.0000051823945,0.00093721197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992322,0.000037881386,0.000072374554,0.00011265459,0.00036464565,0.00018021098],"domain_scores_gemma":[0.99796873,0.000051798615,0.0007600501,0.000053986594,0.00075459573,0.00041075968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005639534,0.00031374177,0.00038939074,0.0010881864,0.0015337317,0.0006882626,0.0010028429,0.00046923765,0.0011340983],"category_scores_gemma":[0.0017921106,0.00041519167,0.00073041284,0.003493647,0.0005026035,0.00052885956,0.0007247018,0.00057960645,0.00023450579],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003606672,0.000027821978,0.9965203,0.00005714958,0.000046597754,0.000052354004,0.00065847713,0.000038748003,0.000112840215,0.00001844497,0.0010169735,0.0014141892],"study_design_scores_gemma":[0.0000043621567,0.000016079306,0.99886084,0.000019278594,0.000016886874,0.000023950215,0.00036898383,0.00006314206,0.000013159729,0.0000038130847,0.0006060014,0.0000035493183],"about_ca_topic_score_codex":0.97327685,"about_ca_topic_score_gemma":0.98636067,"teacher_disagreement_score":0.026723146,"about_ca_system_score_codex":0.014577255,"about_ca_system_score_gemma":0.015780503,"threshold_uncertainty_score":0.10576588},"labels":[],"label_agreement":null},{"id":"W2789541411","doi":"10.1177/2045125318762365","title":"Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial","year":2018,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University","funders":"Cilag; Health Technology Assessment Programme; H. Lundbeck A/S; Otsuka Pharmaceutical; Amicus Therapeutics; National Institute for Health and Care Research; Sunovion; Eli Lilly and Company","keywords":"Amisulpride; Clozapine; Positive and Negative Syndrome Scale; Tolerability; Placebo; Adverse effect; Medicine; Scale for the Assessment of Negative Symptoms; Internal medicine; Randomized controlled trial; Antipsychotic; Atypical antipsychotic; Schizophrenia (object-oriented programming); Psychology; Psychiatry; Psychosis; Brief Psychiatric Rating Scale","score_opus":0.0536004326467893,"score_gpt":0.4385091208658433,"score_spread":0.384908688219054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789541411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94794995,0.026992397,0.0019368582,0.0015461651,0.0023193497,0.014942542,0.0012297714,0.0003215823,0.0027615102],"genre_scores_gemma":[0.96157575,0.012176164,0.003479099,0.0017291764,0.0016336398,0.014865122,0.00076150795,0.000043993077,0.0037355158],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99793637,0.0011512291,0.00024824834,0.00031630616,0.00017224679,0.00017554524],"domain_scores_gemma":[0.997595,0.00088464055,0.00056754955,0.00024154196,0.00024400074,0.00046723097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004362465,0.0020629594,0.0049885307,0.0008283822,0.00080391084,0.0015526415,0.0012586532,0.0037743286,0.007075079],"category_scores_gemma":[0.004753641,0.0009724967,0.0031858964,0.0007204308,0.001751311,0.0012519074,0.00048435273,0.0023823867,0.0011950516],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9852063,0.0026497808,0.00018806495,0.001705026,0.0011827125,0.000036117006,0.00004730633,0.00009106993,0.0018389809,0.000057148703,0.00025807295,0.0067395773],"study_design_scores_gemma":[0.979483,0.019148368,0.00036580657,0.00005895801,0.00042014068,0.000016223908,0.000009240526,0.0001068862,0.00013082664,0.000043085303,0.0002093269,0.000008200671],"about_ca_topic_score_codex":0.00095018756,"about_ca_topic_score_gemma":0.0018128996,"teacher_disagreement_score":0.007075079,"about_ca_system_score_codex":0.00088096166,"about_ca_system_score_gemma":0.0016330673,"threshold_uncertainty_score":0.023668468},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W2794315745","doi":"10.1177/2045125318762911","title":"Rethinking the spectrum of mood disorders: implications for diagnosis and management – Proceedings of a symposium presented at the 30th Annual European College of Neuropsychopharmacology Congress, 4 September 2017, Paris, France","year":2018,"lang":"en","type":"review","venue":"Therapeutic Advances in Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"National Institute for Health and Care Research; Wellcome Trust","keywords":"Psychiatry; Ziprasidone; Mania; Bipolar disorder; Psychology; Neuropsychopharmacology; Mood; Irritability; Lurasidone; Clinical psychology; Antipsychotic; Cognition; Schizophrenia (object-oriented programming)","score_opus":0.027248999751433092,"score_gpt":0.37955691082565884,"score_spread":0.35230791107422577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794315745","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010874165,0.1868304,0.0035416565,0.7775275,0.02618378,0.00008296057,0.00011728551,0.00008144936,0.0045475448],"genre_scores_gemma":[0.047207482,0.5842554,0.03723287,0.17399217,0.14754899,0.00056198455,0.00073785364,0.0001596684,0.008303641],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950991,0.0025676757,0.00071834517,0.00039951818,0.0009603633,0.00025486195],"domain_scores_gemma":[0.9780262,0.0090003535,0.0014344341,0.00072893413,0.007806369,0.0030036964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025014807,0.00090079976,0.0018483179,0.0024062558,0.0018263619,0.007717362,0.0020823188,0.0035315745,0.0051534562],"category_scores_gemma":[0.027134344,0.0004475114,0.0009215184,0.0011790262,0.0053266063,0.008960691,0.0041735703,0.01316874,0.0020151322],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011843283,0.000078747296,0.002397916,0.0015374335,0.000077708304,0.0005258787,0.0016953575,0.0002553355,0.000704901,0.012427898,0.4341995,0.5459809],"study_design_scores_gemma":[0.000087744906,0.0001746048,0.011805859,0.0126582915,0.00008300932,0.0016940782,0.0063139955,0.00040346917,0.00015897871,0.058495924,0.907995,0.00012896176],"about_ca_topic_score_codex":0.005074456,"about_ca_topic_score_gemma":0.015795462,"teacher_disagreement_score":0.025014807,"about_ca_system_score_codex":0.004041366,"about_ca_system_score_gemma":0.008880193,"threshold_uncertainty_score":0.13229251},"labels":[],"label_agreement":null},{"id":"W2809021766","doi":"10.1177/2045125318782694","title":"Real-world effectiveness of long-acting antipsychotic treatments in a nationwide cohort of 3957 patients with schizophrenia, schizoaffective disorder and other diagnoses in Quebec","year":2018,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Paliperidone; Schizoaffective disorder; Antipsychotic; Medicine; Medical prescription; Risperidone; Cohort; Leaf area index; Aripiprazole; Psychiatry; Schizophrenia (object-oriented programming); Internal medicine; Psychosis; Pharmacology","score_opus":0.011005143346642425,"score_gpt":0.36126976310544434,"score_spread":0.3502646197588019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809021766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955837,0.00028056468,0.000058726826,0.000107490574,0.000005816662,0.000030221676,0.0035327266,0.000004397314,0.0003964299],"genre_scores_gemma":[0.99788946,0.00013113405,0.000072438226,0.00006234385,0.000004311245,0.000018305213,0.0016481002,0.0000016345111,0.00017241223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990827,0.00018490695,0.00009725456,0.00020862342,0.0001899045,0.00023657925],"domain_scores_gemma":[0.99736685,0.0003605336,0.0010965621,0.00013566436,0.000565224,0.0004752048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007856648,0.00035837237,0.0004167856,0.000753402,0.0012454635,0.001089637,0.00093766476,0.00059833704,0.0017947434],"category_scores_gemma":[0.0025985676,0.00029067308,0.0006822226,0.0023151229,0.000543608,0.00052257464,0.00067574624,0.00066881574,0.00022387566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007105053,0.000041554853,0.99820304,0.00001262679,0.000080869395,0.000039608793,0.000115289324,0.00012173717,0.000065370594,0.000016303356,0.00031333748,0.0009192031],"study_design_scores_gemma":[0.00001314569,0.00004009685,0.9988273,0.000011456934,0.00002303873,0.000035369558,0.0002973178,0.0005472711,0.000016369268,0.000006951553,0.00017651635,0.000005302386],"about_ca_topic_score_codex":0.9362364,"about_ca_topic_score_gemma":0.9428979,"teacher_disagreement_score":0.06376362,"about_ca_system_score_codex":0.012864087,"about_ca_system_score_gemma":0.0052159303,"threshold_uncertainty_score":0.1282782},"labels":[],"label_agreement":null},{"id":"W2901327393","doi":"10.1177/2045125318791944","title":"Anti-cytokine agents for anhedonia: targeting inflammation and the immune system to treat dimensional disturbances in depression","year":2018,"lang":"en","type":"review","venue":"Therapeutic Advances in Psychopharmacology","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Brain and Cognition Discovery Foundation; University Health Network","funders":"","keywords":"Anhedonia; Neuroscience; Medicine; Mood disorders; Bipolar disorder; Major depressive disorder; Mood; Neurology; Psychology; Bioinformatics; Schizophrenia (object-oriented programming); Psychiatry; Biology","score_opus":0.03277038574245015,"score_gpt":0.3772178966809679,"score_spread":0.3444475109385177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901327393","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13584584,0.82016915,0.004928658,0.015602305,0.002166342,0.0011905283,0.00046818738,0.0002077662,0.019421216],"genre_scores_gemma":[0.4605899,0.49535108,0.012895483,0.01420503,0.0025722794,0.0011916325,0.0006304772,0.00003957675,0.012524531],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997998,0.000079244826,0.000021908625,0.00002008649,0.000047651596,0.000031265525],"domain_scores_gemma":[0.99978775,0.000058039786,0.00006483852,0.000010835274,0.000038864157,0.00003975477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068544527,0.0003242726,0.0006570723,0.00059806596,0.00021018687,0.0007766204,0.0004409365,0.00080857886,0.0042399964],"category_scores_gemma":[0.0006462951,0.00012885872,0.0008610627,0.00030280967,0.00030343593,0.0006013526,0.00034852402,0.0017893073,0.0008028406],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00801603,0.003533553,0.0010145738,0.0076727998,0.00069119275,0.00040881964,0.00017825652,0.0004018184,0.023343235,0.003564952,0.014310379,0.9368643],"study_design_scores_gemma":[0.091343164,0.08144601,0.056319315,0.019855987,0.0044000056,0.006902914,0.001051764,0.0042077317,0.025550492,0.019051671,0.689647,0.00022387836],"about_ca_topic_score_codex":0.0005677625,"about_ca_topic_score_gemma":0.0032127867,"teacher_disagreement_score":0.0042399964,"about_ca_system_score_codex":0.00033983804,"about_ca_system_score_gemma":0.00043163873,"threshold_uncertainty_score":0.0141842365},"labels":[],"label_agreement":null},{"id":"W2953902282","doi":"10.1177/2045125319859973","title":"The association between hormones and antipsychotic use: a focus on postpartum and menopausal women","year":2019,"lang":"en","type":"review","venue":"Therapeutic Advances in Psychopharmacology","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Antipsychotic; Hormone; Medicine; Association (psychology); Pregnancy; Psychiatry; Focus (optics); Psychology; Obstetrics; Physiology; Schizophrenia (object-oriented programming); Internal medicine; Psychotherapist; Biology","score_opus":0.046979743434096326,"score_gpt":0.41131884118999695,"score_spread":0.3643390977559006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953902282","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003313981,0.99552464,0.000049488932,0.0005625566,0.00012442323,0.000005499032,0.0000424304,0.0000011324856,0.0003759475],"genre_scores_gemma":[0.012949335,0.9856523,0.00011557129,0.00061144796,0.00038457158,0.0000119586175,0.00004278863,0.0000016608556,0.00023028502],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974555,0.0000869848,0.000056631787,0.000045068842,0.000038091952,0.000027667515],"domain_scores_gemma":[0.99905914,0.00067654887,0.00015902812,0.00000886974,0.000067183755,0.000029256176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004784386,0.0003681356,0.0008977944,0.001286314,0.0002385813,0.0007745627,0.00024117115,0.0006695712,0.002486635],"category_scores_gemma":[0.0014479443,0.00018311811,0.00077942107,0.0018853606,0.00026891247,0.0008491914,0.0006352769,0.00053701224,0.00020660106],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011400146,0.00016060431,0.030351013,0.13486527,0.001688979,0.004173439,0.004159568,0.00022573258,0.0024781628,0.0031421448,0.017719036,0.799896],"study_design_scores_gemma":[0.0001473454,0.0017038279,0.218461,0.1332671,0.00783148,0.03164846,0.006914,0.0002473188,0.0010506412,0.004408982,0.59417456,0.00014518088],"about_ca_topic_score_codex":0.0019167144,"about_ca_topic_score_gemma":0.0027497578,"teacher_disagreement_score":0.002486635,"about_ca_system_score_codex":0.00040563042,"about_ca_system_score_gemma":0.0007227579,"threshold_uncertainty_score":0.008318663},"labels":[],"label_agreement":null},{"id":"W3025130047","doi":"10.1177/2045125320916657","title":"Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Misericordia Community Hospital; Grey Nuns Community Hospital; University of Alberta","funders":"University of Alberta","keywords":"Ketamine; Antidepressant; Neuroscience; AMPA receptor; Medicine; Pharmacology; NMDA receptor; Mechanism (biology); Mechanism of action; Psychology; Hippocampus; Receptor; Internal medicine; Biology","score_opus":0.046327182449684125,"score_gpt":0.40158836054018215,"score_spread":0.355261178090498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025130047","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001001651,0.99519926,0.0011112221,0.0009184599,0.00009619463,0.000022225024,0.000052341078,0.0000175983,0.0015811449],"genre_scores_gemma":[0.005304212,0.9917714,0.001480628,0.00039005745,0.0005129093,0.000025574967,0.00008210554,0.0000030122362,0.00043012513],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997205,0.00006277701,0.000064506115,0.000054369506,0.00007730656,0.00002052501],"domain_scores_gemma":[0.999691,0.00013539947,0.00007486917,0.0000075011285,0.00006801856,0.000023201153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006548623,0.0009347858,0.00093548564,0.001818923,0.00022408858,0.0011793306,0.0005101864,0.0009973291,0.0012100782],"category_scores_gemma":[0.00051529665,0.00033974863,0.0004717494,0.0011169029,0.00043425942,0.0013322383,0.00047532024,0.0015772878,0.00079128],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004455078,0.00026507012,0.0034807057,0.015416195,0.00022394424,0.0007921463,0.00013248003,0.0012769082,0.012028797,0.012940316,0.015149251,0.93784875],"study_design_scores_gemma":[0.00007693094,0.0022370403,0.0249054,0.008538041,0.0008762716,0.017551081,0.00030776046,0.0030924904,0.0076492587,0.021032723,0.91357774,0.000155271],"about_ca_topic_score_codex":0.0012439673,"about_ca_topic_score_gemma":0.0017937279,"teacher_disagreement_score":0.001818923,"about_ca_system_score_codex":0.0008060944,"about_ca_system_score_gemma":0.0008754243,"threshold_uncertainty_score":0.005848646},"labels":[],"label_agreement":null},{"id":"W3045046035","doi":"10.1177/2045125320942703","title":"Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches","year":2020,"lang":"en","type":"review","venue":"Therapeutic Advances in Psychopharmacology","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Mental Health; Berlin Institute of Health; Patient-Centered Outcomes Research Institute; Thrasher Research Fund","keywords":"Delirium; Medicine; Intensive care medicine; Haloperidol; Placebo; Population; Adverse effect; Intensive care unit; Dementia; Cochrane Library; Intensive care; MEDLINE; Psychomotor agitation; Psychiatry; Disease; Randomized controlled trial; Pharmacology; Alternative medicine; Internal medicine","score_opus":0.129382866224471,"score_gpt":0.44650236377916813,"score_spread":0.31711949755469715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045046035","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000401097,0.99827206,0.000081119695,0.0008474502,0.00013839755,0.00001887843,0.000018803288,0.0000028870559,0.00021928297],"genre_scores_gemma":[0.009331545,0.98773336,0.0007206545,0.0016432834,0.00035642815,0.00007002327,0.000041411757,0.0000038019161,0.000099446566],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943252,0.0024192834,0.001786384,0.0004379428,0.00088716834,0.00014394046],"domain_scores_gemma":[0.9821883,0.013461484,0.0022041951,0.00031002407,0.0016580132,0.00017802743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007501313,0.00082654704,0.004301852,0.0034697999,0.00034771406,0.0024216073,0.0017553571,0.0017372303,0.0022492947],"category_scores_gemma":[0.018976888,0.0004917692,0.004264258,0.0020053105,0.000997646,0.0032918733,0.0010792927,0.0026511007,0.00034664053],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009822245,0.00012012335,0.00084562734,0.47345778,0.004534528,0.00023029155,0.00047015556,0.0002869495,0.0007313191,0.0022373986,0.005629419,0.5104742],"study_design_scores_gemma":[0.0018813984,0.0014077154,0.009985562,0.789713,0.021562183,0.0013026325,0.00121389,0.0005125772,0.0006760015,0.006085551,0.1655209,0.00013858835],"about_ca_topic_score_codex":0.0042435313,"about_ca_topic_score_gemma":0.0106342435,"teacher_disagreement_score":0.007501313,"about_ca_system_score_codex":0.0020905272,"about_ca_system_score_gemma":0.0038454013,"threshold_uncertainty_score":0.039671242},"labels":[],"label_agreement":null},{"id":"W3086033671","doi":"10.1177/2045125320957118","title":"Use of long acting antipsychotics and relationship to newly diagnosed bipolar disorder: a pragmatic longitudinal study based on a Canadian health registry","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Institut universitaire en santé mentale de Montréal","funders":"","keywords":"Bipolar disorder; Psychiatry; Schizophrenia (object-oriented programming); Risperidone; Antipsychotic; Schizoaffective disorder; Medicine; Mood disorders; Mood; Not Otherwise Specified; Pediatrics; Psychosis; Psychology; Anxiety","score_opus":0.07870364964890418,"score_gpt":0.41509499810356615,"score_spread":0.33639134845466195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3086033671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892898,0.0005926563,0.00022876386,0.0003820659,0.00001063555,0.00031168133,0.0076553375,0.000014062296,0.0015150139],"genre_scores_gemma":[0.9940356,0.0005677468,0.00053612044,0.00029260243,0.000011367098,0.00020537539,0.0038626045,0.000010468337,0.00047801054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99721706,0.00054508256,0.00023079476,0.0004955973,0.0008237316,0.00068782177],"domain_scores_gemma":[0.9899082,0.0008119448,0.0026234332,0.0005186331,0.0045771855,0.0015605708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030220654,0.00063300744,0.00089364225,0.0031058695,0.004664722,0.001953389,0.0016041588,0.00078780187,0.002313304],"category_scores_gemma":[0.005983131,0.0006776129,0.0010341558,0.008909055,0.0009762485,0.0010072187,0.0016732662,0.0010172892,0.00037490192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014631692,0.000087499815,0.9961965,0.000042444095,0.00009116928,0.00011161115,0.00071284047,0.00006578894,0.000094708244,0.000056329176,0.00078085635,0.0016139173],"study_design_scores_gemma":[0.000039184393,0.000103606406,0.9974457,0.00004048021,0.00005279172,0.00008762766,0.0012266556,0.00031910645,0.000029123008,0.00001293412,0.00062008185,0.000022821512],"about_ca_topic_score_codex":0.98570967,"about_ca_topic_score_gemma":0.9893091,"teacher_disagreement_score":0.03668268,"about_ca_system_score_codex":0.03668268,"about_ca_system_score_gemma":0.037924305,"threshold_uncertainty_score":0.26615274},"labels":[],"label_agreement":null},{"id":"W3161225466","doi":"10.1177/20451253211013148","title":"Anxiety symptoms in working patients with major depressive disorder treated with vortioxetine: associations with clinical and treatment outcomes in the AtWoRC study","year":2021,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grey Nuns Community Hospital","funders":"Lundbeck Canada; H. Lundbeck A/S","keywords":"Vortioxetine; Anxiety; Major depressive disorder; Generalized anxiety disorder; Psychiatry; Post-hoc analysis; Psychology; Depression (economics); Anxiety disorder; Clinical psychology; Cognition; Medicine; Internal medicine","score_opus":0.019250033915335762,"score_gpt":0.3741020661297704,"score_spread":0.3548520322144347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161225466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99899536,0.00057239394,0.000023791865,0.000044261877,0.000008289653,0.000014656471,0.0001550364,0.0000014725141,0.00018464096],"genre_scores_gemma":[0.99930716,0.00023776277,0.000040110837,0.000034111366,0.000017328228,0.000013312496,0.00028294598,7.314593e-7,0.00006660292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966466,0.00012491053,0.00004189984,0.000042702286,0.00007532849,0.000050516373],"domain_scores_gemma":[0.99874395,0.00017907625,0.00068668876,0.00006051347,0.00009554067,0.00023426795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000702567,0.00019911534,0.00047276766,0.0003628565,0.00021608741,0.0005524489,0.0002109092,0.00031725343,0.0005805002],"category_scores_gemma":[0.0014083988,0.00015929315,0.0004897331,0.00040819487,0.00013999443,0.000174716,0.00028423977,0.00044798027,0.000072360664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037437128,0.00033785473,0.98740155,0.00007498698,0.00069721293,0.000088203196,0.00009585,0.000061975894,0.0006830023,0.000013722882,0.00024178567,0.0065602083],"study_design_scores_gemma":[0.00017506008,0.000638377,0.9986884,0.000009934573,0.00012956565,0.00009270906,0.000044869495,0.00007617665,0.00003190304,0.000008290504,0.00010126793,0.0000033528054],"about_ca_topic_score_codex":0.001176218,"about_ca_topic_score_gemma":0.0022078645,"teacher_disagreement_score":0.001176218,"about_ca_system_score_codex":0.0002017736,"about_ca_system_score_gemma":0.0001583287,"threshold_uncertainty_score":0.0037155151},"labels":[],"label_agreement":null},{"id":"W3203579560","doi":"10.1177/20451253211042696","title":"Repetitive transcranial magnetic stimulation for major depressive disorder: basic principles and future directions","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Psychopharmacology","topic":"Transcranial Magnetic Stimulation Studies","field":"Neuroscience","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; Université de Montréal; Centre Hospitalier de l’Université de Montréal; University of Toronto","funders":"","keywords":"Transcranial magnetic stimulation; Major depressive disorder; Randomized controlled trial; Deep transcranial magnetic stimulation; Psychiatry; Physical medicine and rehabilitation; Medicine; Clinical trial; Psychology; Intervention (counseling); Neuroscience; Stimulation; Psychotherapist; Mood; Internal medicine","score_opus":0.05025182910289159,"score_gpt":0.3985004129276553,"score_spread":0.3482485838247637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203579560","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000036501027,0.99924135,0.000067468914,0.0003378863,0.00008101097,0.0000060519046,0.0000086421505,0.000003146872,0.00021795522],"genre_scores_gemma":[0.00022959425,0.99924624,0.00017367,0.0001944042,0.00006718199,0.000009878724,0.000009112962,6.1081397e-7,0.000069311725],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970454,0.000078651545,0.00006514289,0.00005133998,0.000081418366,0.000018905175],"domain_scores_gemma":[0.99931324,0.00046746698,0.00008031536,0.000015951859,0.00010003599,0.000022982906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014016725,0.0010223688,0.0017204498,0.0020933163,0.00027204462,0.0011307203,0.0011162598,0.0013742134,0.0030271383],"category_scores_gemma":[0.0015207916,0.00033708086,0.0011277748,0.0022256032,0.0006210506,0.0017923368,0.0005729404,0.0020566247,0.0011061471],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011102778,0.000081551705,0.00014421559,0.07607999,0.0002137149,0.0001262965,0.00007588063,0.00028620803,0.00078070106,0.00528697,0.0141215585,0.90269184],"study_design_scores_gemma":[0.00013134877,0.0003922285,0.0022964033,0.069544725,0.00088433444,0.0014741205,0.00017659644,0.00025703013,0.0004573954,0.01094614,0.9133823,0.000057444555],"about_ca_topic_score_codex":0.0013654272,"about_ca_topic_score_gemma":0.0026431396,"teacher_disagreement_score":0.0030271383,"about_ca_system_score_codex":0.0008364764,"about_ca_system_score_gemma":0.0019211784,"threshold_uncertainty_score":0.01012677},"labels":[],"label_agreement":null},{"id":"W4211248784","doi":"10.1177/20451253211067656","title":"Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression: a systematic review","year":2022,"lang":"en","type":"review","venue":"Therapeutic Advances in Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Guideline; Discontinuation; Medicine; Tapering; Clinical Practice; Depression (economics); MEDLINE; Psychiatry; Systematic review; Intensive care medicine; Family medicine","score_opus":0.09605445448766545,"score_gpt":0.5505624192574015,"score_spread":0.454507964769736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211248784","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023675726,0.93765956,0.003957296,0.032764185,0.0035644325,0.010039448,0.005122235,0.00019556892,0.00432971],"genre_scores_gemma":[0.022143869,0.9088199,0.03575772,0.0126388185,0.00071110984,0.014622684,0.004047551,0.000072030125,0.0011861895],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9373948,0.023872728,0.023624837,0.0026282487,0.011424488,0.0010549321],"domain_scores_gemma":[0.81645834,0.094316274,0.042681072,0.0028920833,0.040994324,0.0026579015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.046953425,0.0017697075,0.007507578,0.014786379,0.0015852336,0.0034795166,0.0057157627,0.005142216,0.0055289213],"category_scores_gemma":[0.21657005,0.002013104,0.0080093,0.015392158,0.0020552247,0.005325311,0.0029841836,0.0039577372,0.0012324865],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018786061,0.00004797855,0.002236653,0.7597673,0.004385816,0.00015206047,0.0010382334,0.00039841616,0.00023199018,0.0013877421,0.06370675,0.16645923],"study_design_scores_gemma":[0.00039964274,0.00007186815,0.0025765034,0.936729,0.007588325,0.0001567592,0.00037291087,0.000177873,0.00010517211,0.0013247988,0.050443947,0.00005320747],"about_ca_topic_score_codex":0.023757705,"about_ca_topic_score_gemma":0.064029284,"teacher_disagreement_score":0.046953425,"about_ca_system_score_codex":0.009377349,"about_ca_system_score_gemma":0.040416744,"threshold_uncertainty_score":0.2483164},"labels":[],"label_agreement":null},{"id":"W4285226678","doi":"10.1177/20451253221096525","title":"Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review","year":2022,"lang":"en","type":"review","venue":"Therapeutic Advances in Psychopharmacology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; McMaster University; Population Health Research Institute; University of Toronto; Centre for Addiction and Mental Health","funders":"Banting and Best Diabetes Centre, University of Toronto; Canadian Institutes of Health Research","keywords":"Schizophrenia (object-oriented programming); Medicine; Context (archaeology); Metabolic syndrome; Antipsychotic; Microbiome; Bipolar disorder; Bioinformatics; Prebiotic; Gut flora; Obesity; Psychiatry; Internal medicine; Immunology; Biology; Lithium (medication); Genetics","score_opus":0.05052236595574217,"score_gpt":0.44699695043089305,"score_spread":0.3964745844751509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285226678","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029870312,0.9984952,0.00011089983,0.00028496934,0.00015304716,0.00006304135,0.00017391905,0.000005704365,0.00041446148],"genre_scores_gemma":[0.0018418051,0.99731135,0.00021717399,0.00019618408,0.00007471916,0.00008773953,0.00012472537,0.0000023847506,0.00014397317],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99842477,0.0003967183,0.0006239166,0.00016358326,0.00029453862,0.000096443735],"domain_scores_gemma":[0.99245065,0.005621867,0.0010330126,0.000101355465,0.0006885865,0.00010455509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002858541,0.0012479733,0.0038026604,0.0103252875,0.0008270154,0.002985882,0.001168675,0.0019348752,0.005915772],"category_scores_gemma":[0.014575632,0.0006449497,0.004161959,0.009164022,0.0006179585,0.0018125578,0.0018040318,0.0011731884,0.00062702695],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013221003,0.000032350064,0.00069780607,0.74901634,0.0022050457,0.00023256753,0.00048550856,0.00028154202,0.00034804945,0.0015012933,0.008451817,0.2366154],"study_design_scores_gemma":[0.00003125605,0.00009268504,0.002236949,0.8797568,0.010316401,0.0006044642,0.0003645073,0.000099811055,0.00016550273,0.0010687835,0.10522741,0.000035412577],"about_ca_topic_score_codex":0.008313522,"about_ca_topic_score_gemma":0.01616893,"teacher_disagreement_score":0.0103252875,"about_ca_system_score_codex":0.0020439266,"about_ca_system_score_gemma":0.009236219,"threshold_uncertainty_score":0.019790173},"labels":[],"label_agreement":null},{"id":"W4285285921","doi":"10.1177/20451253221092931","title":"Treatment strategies for clozapine-induced hypotension: a systematic review","year":2022,"lang":"en","type":"review","venue":"Therapeutic Advances in Psychopharmacology","topic":"Cardiovascular Syncope and Autonomic Disorders","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Clozapine; Midodrine; Orthostatic vital signs; Fludrocortisone; Adverse effect; Anesthesia; Intensive care medicine; Blood pressure; Schizophrenia (object-oriented programming); Internal medicine; Psychiatry","score_opus":0.07833255252797681,"score_gpt":0.4407979264225165,"score_spread":0.36246537389453964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285285921","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005606768,0.99826187,0.000107556385,0.0002077457,0.00006980164,0.00036668964,0.00013872318,0.000009803021,0.0002771656],"genre_scores_gemma":[0.007932452,0.9900131,0.00071287114,0.00042734187,0.000046498335,0.00060935516,0.00013354467,0.000004330079,0.00012043923],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9957943,0.0016414284,0.0014035136,0.00024669094,0.0007682131,0.00014589562],"domain_scores_gemma":[0.98873144,0.007695061,0.002315606,0.00013088895,0.00095524767,0.00017172702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005132443,0.0014660927,0.0067811687,0.008191264,0.0006602681,0.0020233875,0.0018992798,0.0018111859,0.0060008243],"category_scores_gemma":[0.020526733,0.0008746106,0.006671051,0.007371008,0.0006746571,0.0020050139,0.001235392,0.0012504535,0.00038265396],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020670092,0.000022513706,0.00019965401,0.937785,0.003546226,0.00006897865,0.00015396363,0.0000810102,0.00008236569,0.0001824065,0.001380108,0.056290966],"study_design_scores_gemma":[0.00046926743,0.00024909095,0.0015412077,0.9447254,0.034365974,0.0002753848,0.00028787457,0.00009588568,0.00012714959,0.00024498557,0.01758725,0.00003065971],"about_ca_topic_score_codex":0.009746523,"about_ca_topic_score_gemma":0.026784535,"teacher_disagreement_score":0.009746523,"about_ca_system_score_codex":0.004311358,"about_ca_system_score_gemma":0.010447684,"threshold_uncertainty_score":0.031281173},"labels":[],"label_agreement":null},{"id":"W4309656230","doi":"10.1177/20451253221136021","title":"Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation","year":2022,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Dalhousie University; Université Laval; Douglas Mental Health University Institute; Institut Universitaire en Santé Mentale de Québec","funders":"Janssen Research and Development","keywords":"Paliperidone Palmitate; Medicine; Hazard ratio; Schizophrenia (object-oriented programming); Confidence interval; Paliperidone; Psychiatry; Psychopathology; Relapse prevention; Internal medicine; Randomized controlled trial; Retrospective cohort study; Antipsychotic; Pediatrics","score_opus":0.023845416608878935,"score_gpt":0.3623951410027052,"score_spread":0.33854972439382625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309656230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99892944,0.000560546,0.00002937457,0.00007565769,0.0000075902935,0.00002504385,0.00008698303,0.0000050438,0.00028036002],"genre_scores_gemma":[0.9995778,0.00016348272,0.000070868766,0.00003224318,0.0000067220335,0.000014011617,0.000071250295,6.740563e-7,0.00006293324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989899,0.00040659058,0.000104427774,0.00012913444,0.00021418769,0.00015575503],"domain_scores_gemma":[0.9974279,0.0005053182,0.0012563734,0.000119399454,0.00020394693,0.00048709332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016515189,0.00021492729,0.00041302564,0.00017078026,0.00030374358,0.00053389074,0.000316186,0.00036601495,0.0010149031],"category_scores_gemma":[0.0053109657,0.000107160966,0.00063730904,0.00022248,0.0002892171,0.0002894596,0.00028459498,0.0005958002,0.00010941777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1051046,0.010119789,0.66491157,0.00062731793,0.0014377278,0.00037142288,0.0010653919,0.002681573,0.0034445447,0.00016768114,0.0011103259,0.20895812],"study_design_scores_gemma":[0.0028225784,0.04812128,0.9428681,0.000113353344,0.0006226312,0.0003011626,0.00045110652,0.002482015,0.0010266579,0.00008450193,0.001070512,0.000036135047],"about_ca_topic_score_codex":0.024768984,"about_ca_topic_score_gemma":0.030167151,"teacher_disagreement_score":0.024768984,"about_ca_system_score_codex":0.0019314023,"about_ca_system_score_gemma":0.0018382514,"threshold_uncertainty_score":0.04924959},"labels":[],"label_agreement":null},{"id":"W4319349727","doi":"10.1177/20451253231151327","title":"Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review","year":2023,"lang":"en","type":"review","venue":"Therapeutic Advances in Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Ketamine; Psychology; Psychiatry; Medicine; Psychotherapist","score_opus":0.05058366307446651,"score_gpt":0.46535979085611673,"score_spread":0.41477612778165024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319349727","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007641995,0.9986161,0.00006001895,0.00012474072,0.000051028976,0.00012877455,0.00014425836,0.0000045625598,0.000106307176],"genre_scores_gemma":[0.012737903,0.9861012,0.00031742302,0.00030976845,0.000063652165,0.00026371217,0.00014112372,0.0000028051352,0.00006246234],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9960592,0.0013272234,0.0014983771,0.00029470347,0.0006940729,0.00012651017],"domain_scores_gemma":[0.9862574,0.0089149745,0.003290824,0.00018905796,0.0011364461,0.00021132514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005035399,0.001259275,0.008224709,0.0060171555,0.00048698272,0.0017774395,0.0014286484,0.0016378257,0.0036658533],"category_scores_gemma":[0.01766086,0.0007852408,0.008171561,0.006039654,0.0006546969,0.0014880706,0.0011835,0.00095559994,0.00023553634],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032125128,0.0000198254,0.00070851087,0.95557904,0.01263794,0.000074482894,0.0000798084,0.000086702785,0.00010678771,0.00010996033,0.0010344787,0.029241284],"study_design_scores_gemma":[0.0006020085,0.00039548302,0.006501816,0.805802,0.17060427,0.0005457897,0.00020125874,0.00014054947,0.00019117298,0.00033406154,0.014637052,0.00004460249],"about_ca_topic_score_codex":0.0057735993,"about_ca_topic_score_gemma":0.017276246,"teacher_disagreement_score":0.008224709,"about_ca_system_score_codex":0.0020795106,"about_ca_system_score_gemma":0.0073864968,"threshold_uncertainty_score":0.026630044},"labels":[],"label_agreement":null},{"id":"W4366433723","doi":"10.1177/20451253231165169","title":"Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin – a case series","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Banting and Best Diabetes Centre, University of Toronto; Canadian Institutes of Health Research; National Health and Medical Research Council; Department of Psychiatry, University of Toronto; HLS Therapeutics; Physicians' Services Incorporated Foundation; University of Toronto; Steno Diabetes Center Copenhagen","keywords":"Metformin; Semaglutide; Antipsychotic; Weight gain; Medicine; Risperidone; Series (stratigraphy); Internal medicine; Psychiatry; Psychology; Body weight; Psychotherapist; Schizophrenia (object-oriented programming); Endocrinology; Type 2 diabetes; Diabetes mellitus; Biology; Insulin","score_opus":0.027828118838062427,"score_gpt":0.37738513456743106,"score_spread":0.34955701572936865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366433723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9707398,0.009969918,0.0033800923,0.0041710315,0.00059951976,0.0002827052,0.00017645778,0.00012809513,0.010552419],"genre_scores_gemma":[0.9922042,0.0026326294,0.0013724524,0.0013245596,0.0006430653,0.000044487497,0.00009393819,0.00003534346,0.0016492667],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9993481,0.0000951869,0.00011096281,0.00010119729,0.00016431237,0.00018029705],"domain_scores_gemma":[0.99843353,0.00030884115,0.00043525346,0.00009014254,0.00009038995,0.00064190617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038909703,0.0017133272,0.0008272447,0.0023856314,0.0027717417,0.0009878541,0.0010578673,0.0029439686,0.0016148761],"category_scores_gemma":[0.002517714,0.00071207096,0.0015747127,0.0016301064,0.0014104653,0.0010475268,0.0009974445,0.0028006847,0.0006580154],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035619665,0.000076322205,0.00991123,0.000025823714,0.00001996909,0.9863679,0.00019661775,0.0000617332,0.000342264,0.00017013983,0.00032228814,0.0024701173],"study_design_scores_gemma":[0.000013246952,0.0000769678,0.006976448,0.000020625457,0.000017046515,0.99169755,0.00013798257,0.00021686374,0.00017252496,0.00011393398,0.0005455863,0.00001127327],"about_ca_topic_score_codex":0.0047911797,"about_ca_topic_score_gemma":0.00854922,"teacher_disagreement_score":0.0047911797,"about_ca_system_score_codex":0.0015164317,"about_ca_system_score_gemma":0.0012244746,"threshold_uncertainty_score":0.011002541},"labels":[],"label_agreement":null},{"id":"W4378220014","doi":"10.1177/20451253231171512","title":"Safety and tolerability of intramuscular and sublingual ketamine for psychiatric treatment in the Roots To Thrive ketamine-assisted therapy program: a retrospective chart review","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Island University; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"Vancouver Island University","keywords":"Ketamine; Tolerability; Medicine; Failure to thrive; Psychiatry; Adverse effect; Pediatrics; Pharmacology","score_opus":0.03245311796848074,"score_gpt":0.4210666007205402,"score_spread":0.3886134827520595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378220014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916821,0.0036650337,0.00061621226,0.000074587995,0.000009528179,0.0008284671,0.0021795551,0.000018045408,0.0009264244],"genre_scores_gemma":[0.99278283,0.003281987,0.0010288865,0.000122029815,0.000021616424,0.0005379797,0.0019274036,0.000013577723,0.00028370132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99660754,0.0007636183,0.0010331603,0.00043871472,0.00097631075,0.00018072216],"domain_scores_gemma":[0.9810337,0.0044708,0.010973897,0.0005827389,0.0024532012,0.00048570195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029579434,0.00021844609,0.00055651914,0.0024005075,0.00056807644,0.0006391805,0.00054529635,0.00040688037,0.00083095714],"category_scores_gemma":[0.0077338587,0.00034890816,0.0007948531,0.0021087595,0.0004279677,0.0006964108,0.0003881103,0.00055479386,0.00024573097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033438022,0.00018387818,0.981289,0.00073026784,0.000121908444,0.001636949,0.0014304784,0.0001128085,0.00063403766,0.000036818692,0.00054174324,0.012947672],"study_design_scores_gemma":[0.000031542033,0.0014803333,0.98778963,0.0004346427,0.00017976061,0.0046688803,0.0019180545,0.00029437288,0.0007409774,0.000023467604,0.0024036318,0.000034753328],"about_ca_topic_score_codex":0.0042886683,"about_ca_topic_score_gemma":0.0053921933,"teacher_disagreement_score":0.0042886683,"about_ca_system_score_codex":0.0011619544,"about_ca_system_score_gemma":0.0015600697,"threshold_uncertainty_score":0.015643299},"labels":[],"label_agreement":null},{"id":"W4387109635","doi":"10.1177/20451253231202723","title":"Ketamine for bipolar depression: an updated systematic review","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; H. Lundbeck A/S; University of Toronto; Grand Challenges Canada; Centre for Addiction and Mental Health Foundation; Allergan; Physicians' Services Incorporated Foundation; Sunovion","keywords":"Ketamine; Tolerability; Medicine; Dosing; Depression (economics); Dissociative; Randomized controlled trial; Placebo; Bipolar disorder; Treatment-resistant depression; Suicidal ideation; Mood; Adverse effect; Clinical trial; Psychiatry; Major depressive disorder; Anesthesia; Internal medicine; Poison control; Injury prevention; Emergency medicine; Alternative medicine","score_opus":0.02928678094346235,"score_gpt":0.419881327792358,"score_spread":0.3905945468488956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387109635","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046598053,0.99839157,0.000060757036,0.00027142453,0.000097148746,0.00012188633,0.00036698848,0.0000069523126,0.00021724362],"genre_scores_gemma":[0.004034091,0.99487346,0.00023422694,0.00036590948,0.000063255124,0.0001632396,0.0002007102,0.0000028274644,0.00006230842],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99623775,0.0011364772,0.0015003118,0.000276639,0.00069990766,0.00014893824],"domain_scores_gemma":[0.9879921,0.0067840028,0.0032113693,0.00014113702,0.0016498158,0.00022156797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004517109,0.0013447066,0.006521743,0.009326313,0.00046912336,0.0017454703,0.0017240398,0.0014044631,0.005852141],"category_scores_gemma":[0.01909738,0.00082056795,0.0062300274,0.00906556,0.0005653778,0.0021549577,0.001366261,0.0011667213,0.0004439193],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021044024,0.000015153922,0.00063743076,0.9337029,0.0052197636,0.000107951295,0.00011400842,0.00007749694,0.000106236635,0.00016659932,0.0043962616,0.055245783],"study_design_scores_gemma":[0.000431173,0.00024181261,0.0058309645,0.89771634,0.063437514,0.00064037653,0.00020991142,0.00009739172,0.00012126585,0.00030008264,0.030930055,0.00004311958],"about_ca_topic_score_codex":0.010165189,"about_ca_topic_score_gemma":0.031297434,"teacher_disagreement_score":0.010165189,"about_ca_system_score_codex":0.0028647876,"about_ca_system_score_gemma":0.0098674605,"threshold_uncertainty_score":0.023889065},"labels":[],"label_agreement":null},{"id":"W4388763099","doi":"10.1177/20451253231211574","title":"Management of dyslipidaemia in individuals with severe mental illness: a population-based study in the Greater Copenhagen Area","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Novo Nordisk Fonden; Steno Diabetes Center Copenhagen","keywords":"Mental illness; Psychiatry; Medicine; Population; Mental health; Psychology; Gerontology; Clinical psychology; Environmental health","score_opus":0.02999525505515216,"score_gpt":0.385684347543191,"score_spread":0.3556890924880388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388763099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99898297,0.00021768203,0.000037458354,0.000029226116,0.000004232596,0.000012354091,0.0005059285,0.000001353099,0.00020872001],"genre_scores_gemma":[0.999335,0.00012227372,0.00004868497,0.000022017572,0.0000032575272,0.0000074488003,0.00036808115,7.3958495e-7,0.0000925554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919194,0.00016891176,0.00013709451,0.00022681469,0.00014230146,0.00013294019],"domain_scores_gemma":[0.9989779,0.00008124001,0.00053708896,0.00007602757,0.00010473989,0.00022297658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000861187,0.00032996674,0.0005002174,0.00074799627,0.0007893269,0.001057353,0.00051305146,0.00053262385,0.0009188832],"category_scores_gemma":[0.001590726,0.00057910394,0.00092433934,0.0014309161,0.00046385897,0.0005520504,0.0010335451,0.00058224204,0.00012890346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013932317,0.000046746343,0.9982461,0.000029999657,0.00014314194,0.00007028951,0.00042580185,0.0000431401,0.00014614552,0.000023504934,0.000119568766,0.00056621124],"study_design_scores_gemma":[0.000009469092,0.00006591383,0.99917233,0.000012858673,0.00003823224,0.000062260675,0.00042793952,0.00006795941,0.00001356474,0.0000056895096,0.00011902069,0.000004821961],"about_ca_topic_score_codex":0.13123861,"about_ca_topic_score_gemma":0.14458714,"teacher_disagreement_score":0.13123861,"about_ca_system_score_codex":0.0015321975,"about_ca_system_score_gemma":0.0012106542,"threshold_uncertainty_score":0.26094943},"labels":[],"label_agreement":null},{"id":"W4392403691","doi":"10.1177/20451253241231264","title":"Patient-reported outcomes on sleep quality and circadian rhythm during treatment with intravenous ketamine for treatment-resistant depression","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Misericordia Community Hospital; University of Calgary; University of Alberta","funders":"University of Alberta","keywords":"Pittsburgh Sleep Quality Index; Ketamine; Circadian rhythm; Depression (economics); Medicine; Antidepressant; Anesthesia; Population; Internal medicine; Psychology; Sleep quality; Psychiatry; Insomnia; Hippocampus","score_opus":0.02890460389136135,"score_gpt":0.3821951275760406,"score_spread":0.3532905236846793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392403691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995522,0.000110681474,0.000035244495,0.000017272596,0.000002140515,0.000020451378,0.00009412139,0.000001522541,0.00016633791],"genre_scores_gemma":[0.999635,0.0000621883,0.000068959765,0.000014747341,0.0000029347434,0.00001762879,0.00015073277,4.2128295e-7,0.000047321282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995635,0.00017031966,0.000066453445,0.000051015515,0.000098334414,0.000050291885],"domain_scores_gemma":[0.9985739,0.00016619841,0.00087741547,0.000043351643,0.00015263488,0.00018644004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078886026,0.000147985,0.00036281705,0.00016035764,0.00016250598,0.00025017365,0.00016197414,0.0001799012,0.0006036547],"category_scores_gemma":[0.0022401144,0.00008620189,0.00028491887,0.00023101474,0.00011477215,0.00018783145,0.00018725243,0.0003868677,0.00009006663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032718875,0.0007018404,0.97555363,0.000066168206,0.00021920541,0.00009609108,0.00026668533,0.00014083623,0.0021207705,0.000010184412,0.0002668545,0.01728585],"study_design_scores_gemma":[0.00006203391,0.0017917621,0.99759275,0.000006006856,0.000029513227,0.00011179381,0.000060840277,0.00011901399,0.0001420324,0.0000042897636,0.000077015226,0.00000284922],"about_ca_topic_score_codex":0.0008613421,"about_ca_topic_score_gemma":0.0025010933,"teacher_disagreement_score":0.0008613421,"about_ca_system_score_codex":0.00026169958,"about_ca_system_score_gemma":0.00015537551,"threshold_uncertainty_score":0.0041719675},"labels":[],"label_agreement":null},{"id":"W4399176931","doi":"10.1177/20451253241255476","title":"Metformin co-commencement at time of antipsychotic initiation for attenuation of weight gain: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Therapeutic Advances in Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Diabetes Canada; University of Toronto; Centre for Addiction and Mental Health","funders":"Banting and Best Diabetes Centre, University of Toronto; Canadian Institutes of Health Research; National Health and Medical Research Council; Department of Psychiatry, University of Toronto; Novo Nordisk Fonden; University of Toronto; Novo Nordisk; Physicians' Services Incorporated Foundation","keywords":"Metformin; Meta-analysis; Antipsychotic; Medicine; Weight gain; Schizophrenia (object-oriented programming); Internal medicine; Psychiatry; Body weight; Endocrinology; Diabetes mellitus","score_opus":0.1124075638285241,"score_gpt":0.4900142304445053,"score_spread":0.3776066666159812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399176931","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00495205,0.99367505,0.00028185215,0.00015590922,0.0001183986,0.00023044921,0.0003209978,0.000020293277,0.00024496872],"genre_scores_gemma":[0.16655734,0.82880056,0.0017358831,0.0008060989,0.00023565312,0.0008181176,0.0006865177,0.00002426521,0.0003356269],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99481225,0.002382463,0.0014301897,0.00055723946,0.00058396294,0.00023393061],"domain_scores_gemma":[0.99020517,0.006675434,0.0018165623,0.0002710132,0.0008199718,0.00021190777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077419304,0.0022228,0.015498248,0.0043544094,0.0006010489,0.0025333718,0.0019871925,0.0021150825,0.0038307381],"category_scores_gemma":[0.018978242,0.0012608927,0.03444183,0.004735811,0.0005822473,0.001467414,0.0011039386,0.0020178843,0.0002496604],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005614839,0.00006946988,0.003716055,0.41727233,0.5497691,0.0001731497,0.00007638706,0.0006077518,0.00028535203,0.00013456482,0.00083914836,0.021441782],"study_design_scores_gemma":[0.001167111,0.00036657785,0.003748813,0.023086164,0.9694566,0.0000960091,0.000032828186,0.00018875541,0.00013010872,0.00014370003,0.0015609317,0.000022369806],"about_ca_topic_score_codex":0.008163357,"about_ca_topic_score_gemma":0.017426785,"teacher_disagreement_score":0.015498248,"about_ca_system_score_codex":0.0025244998,"about_ca_system_score_gemma":0.0035977867,"threshold_uncertainty_score":0.04094374},"labels":[],"label_agreement":null},{"id":"W4399308963","doi":"10.1177/20451253241257062","title":"Efficacy and safety of long-acting injectable <i>versus</i> oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Therapeutic Advances in Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Teva Pharmaceutical Industries","keywords":"Medicine; Discontinuation; Relative risk; Randomized controlled trial; Pediatrics; Confidence interval; Subgroup analysis; Clinical endpoint; Meta-analysis; Internal medicine; Adverse effect","score_opus":0.060651880436163826,"score_gpt":0.4355056425911378,"score_spread":0.37485376215497396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399308963","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0061848643,0.9921284,0.00037508536,0.00015356098,0.000117158976,0.00037787834,0.00039437384,0.00002189111,0.0002469142],"genre_scores_gemma":[0.18168668,0.8127262,0.00215836,0.0008125982,0.00023293088,0.0013276723,0.0007579678,0.000026891184,0.00027066516],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99175185,0.003819642,0.0025289534,0.00078477326,0.0008873407,0.0002275088],"domain_scores_gemma":[0.981968,0.012622576,0.0036088491,0.00038970308,0.0011633004,0.00024750503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013915557,0.0025773542,0.018282292,0.0050412146,0.00053602626,0.0030433408,0.0020797064,0.0019111589,0.0027650122],"category_scores_gemma":[0.027422788,0.0012510504,0.036721803,0.005417545,0.0007728464,0.0015714607,0.0012364255,0.0018138507,0.00022467734],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035236643,0.000036482357,0.0020236527,0.41171598,0.56993157,0.000073914656,0.00006999294,0.00043092624,0.00024643698,0.00009844396,0.0003521892,0.011496781],"study_design_scores_gemma":[0.00094999396,0.00026856543,0.0020418195,0.023096895,0.97235054,0.0000580644,0.00003223973,0.00013284193,0.00011006893,0.000115856405,0.00082619005,0.000016906975],"about_ca_topic_score_codex":0.0057218797,"about_ca_topic_score_gemma":0.01278214,"teacher_disagreement_score":0.018282292,"about_ca_system_score_codex":0.0030477857,"about_ca_system_score_gemma":0.0034149822,"threshold_uncertainty_score":0.07359338},"labels":[],"label_agreement":null},{"id":"W4401432739","doi":"10.1177/20451253241264812","title":"Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Psychedelics and Drug Studies","field":"Psychology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Victoria","funders":"Natural Sciences and Engineering Research Council of Canada; National Institutes of Health; Heffter Research Institute; Steven and Alexandra Cohen Foundation; Johns Hopkins University","keywords":"Psilocybin; Athletes; Mood; Hallucinogen; Concussion; Cognition; Psychology; Psychiatry; Clinical psychology; Depression (economics); Psychotherapist; Medicine; Poison control; Physical therapy; Injury prevention","score_opus":0.1932787103507804,"score_gpt":0.4232369075555447,"score_spread":0.22995819720476432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401432739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991358,0.00009570895,0.000021801774,0.00011064117,0.000003838012,0.000028760727,0.000034588127,8.3765207e-7,0.0005680863],"genre_scores_gemma":[0.9987232,0.00037754263,0.00014362285,0.00015513407,0.00000889648,0.00004810598,0.000075686665,0.0000011707352,0.00046654072],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9991301,0.00029224638,0.00010894235,0.000057280566,0.00024414164,0.00016723471],"domain_scores_gemma":[0.997569,0.0003405968,0.0012359209,0.000045462482,0.00033028278,0.00047866823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016103381,0.00014536729,0.00022710075,0.00063318125,0.0011282648,0.0012312463,0.0003189268,0.00051202555,0.002195862],"category_scores_gemma":[0.00413155,0.00024948167,0.0005290353,0.00043889578,0.00051056466,0.00053119287,0.00089752366,0.0010192159,0.00026703437],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000959201,0.0007574569,0.98267025,0.0001025299,0.000054992837,0.00010014343,0.0060459743,0.000031301093,0.00028776072,0.00004334559,0.00022399779,0.00958624],"study_design_scores_gemma":[0.000012190855,0.0005130033,0.98012686,0.00008554575,0.000031976142,0.0002275553,0.01785657,0.00014168306,0.0001075894,0.00003074561,0.0008557883,0.000010541827],"about_ca_topic_score_codex":0.011664143,"about_ca_topic_score_gemma":0.022080394,"teacher_disagreement_score":0.011664143,"about_ca_system_score_codex":0.00079342327,"about_ca_system_score_gemma":0.0013013001,"threshold_uncertainty_score":0.023192525},"labels":[],"label_agreement":null},{"id":"W4403798555","doi":"10.1177/20451253241278830","title":"Use of an injection of aripiprazole given once every 2 months (Abilify Asimtufii <sup>®</sup> ) in people with bipolar I disorder: a Plain Language Summary of Publication","year":2024,"lang":"en","type":"review","venue":"Therapeutic Advances in Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"H. Lundbeck A/S; Otsuka Pharmaceutical","keywords":"Aripiprazole; Bipolar disorder; Psychiatry; Psychology; Section (typography); Bipolar I disorder; Schizophrenia (object-oriented programming); Medicine; Pediatrics; Computer science; Lithium (medication)","score_opus":0.02242834406819165,"score_gpt":0.3697333552249572,"score_spread":0.34730501115676554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403798555","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014646948,0.9978023,0.00005316406,0.0003530199,0.0005053631,0.00003171512,0.00013119713,0.0000069477187,0.0009697661],"genre_scores_gemma":[0.00096375437,0.9976743,0.00017162313,0.00037707415,0.00023754433,0.0000300443,0.000111066685,0.0000022032077,0.00043235763],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995227,0.000100027384,0.00014607781,0.00005746873,0.0001477624,0.000026008389],"domain_scores_gemma":[0.9989623,0.0005737309,0.00021708812,0.000015442589,0.0001981502,0.0000333433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012672511,0.0006903714,0.0015431239,0.0018489592,0.00020272352,0.00081152446,0.0007598595,0.00093848124,0.007839033],"category_scores_gemma":[0.002307996,0.0002658934,0.0013264044,0.0015767389,0.00023480513,0.0007426611,0.00039675445,0.0010885954,0.0018562513],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004305592,0.00006159079,0.0001700847,0.16019776,0.00057224697,0.00015595487,0.00005843468,0.000111838795,0.0009819005,0.00079966086,0.047349703,0.7891103],"study_design_scores_gemma":[0.00063126354,0.0008934674,0.0041666552,0.09858176,0.003907728,0.0018922136,0.000115555406,0.00012734707,0.0014480661,0.00080804614,0.88736075,0.00006723185],"about_ca_topic_score_codex":0.0018597266,"about_ca_topic_score_gemma":0.004001859,"teacher_disagreement_score":0.007839033,"about_ca_system_score_codex":0.00058060145,"about_ca_system_score_gemma":0.0013471062,"threshold_uncertainty_score":0.026224136},"labels":[],"label_agreement":null},{"id":"W4404287372","doi":"10.1177/20451253241286319","title":"Plain Language Summary of Publication: A comparison of once-monthly and once-every-2-months injectable formulations of aripiprazole in people with schizophrenia","year":2024,"lang":"en","type":"review","venue":"Therapeutic Advances in Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Eye Institute; Idorsia Pharmaceuticals; H. Lundbeck A/S; Otsuka Pharmaceutical; Eisai; Sunovion; Allergan; HLS Therapeutics; Pfizer; Teva Pharmaceutical Industries; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Aripiprazole; Schizophrenia (object-oriented programming); Section (typography); Psychiatry; Psychology; Medicine; Clinical psychology; Computer science","score_opus":0.03255022006247055,"score_gpt":0.4267247711019088,"score_spread":0.39417455103943827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404287372","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005901031,0.96863616,0.00035983804,0.004822033,0.012023818,0.0006886081,0.00790252,0.00007098583,0.004905843],"genre_scores_gemma":[0.0040708035,0.97369146,0.0010424432,0.0060580047,0.004442332,0.0007054358,0.0044628647,0.000048668244,0.0054778443],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99745685,0.00064475276,0.0009589552,0.00015965616,0.0006808238,0.00009892961],"domain_scores_gemma":[0.99078417,0.0050504017,0.0021643902,0.00010527115,0.0017222763,0.00017347341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032852665,0.0014358507,0.0038804011,0.0035646865,0.00029086962,0.0021070363,0.0013427614,0.001790327,0.042397965],"category_scores_gemma":[0.015600342,0.00041774305,0.0034020662,0.0039889026,0.00043552677,0.0012881818,0.00086653116,0.0014801908,0.00731738],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016566771,0.00006623166,0.00014520646,0.6274793,0.0017705684,0.0001913708,0.00011038196,0.000099863966,0.0015399676,0.0008730279,0.19934627,0.16672115],"study_design_scores_gemma":[0.0018505023,0.0013301963,0.0035061901,0.19653542,0.009477328,0.00070030335,0.00015012594,0.00010807125,0.0013468328,0.00093836774,0.78396434,0.000092408794],"about_ca_topic_score_codex":0.002295449,"about_ca_topic_score_gemma":0.0036842683,"teacher_disagreement_score":0.042397965,"about_ca_system_score_codex":0.0010008657,"about_ca_system_score_gemma":0.0041860365,"threshold_uncertainty_score":0.14183533},"labels":[],"label_agreement":null},{"id":"W4412400181","doi":"10.1177/20451253251356980","title":"Ketamine-assisted therapy within a community of practice: a novel approach to disordered eating","year":2025,"lang":"en","type":"editorial","venue":"Therapeutic Advances in Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Island University","funders":"","keywords":"Disordered eating; Ketamine; Psychotherapist; Medicine; Eating disorders; Psychology; Psychiatry","score_opus":0.032247920176398694,"score_gpt":0.4227301332936612,"score_spread":0.3904822131172625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412400181","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009385594,0.02023088,0.0001990737,0.04371453,0.9341937,0.0000331742,0.00002711814,0.00003630944,0.0014714183],"genre_scores_gemma":[0.00048067226,0.00971276,0.00012438776,0.020185368,0.9672413,0.000025298781,0.000010350824,0.000012144846,0.0022076434],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955623,0.0012883365,0.00076145574,0.00049313164,0.0016419423,0.00025288702],"domain_scores_gemma":[0.9813479,0.0110663315,0.0010375363,0.0003872639,0.0038360856,0.0023248289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074016727,0.0026501415,0.0024612644,0.0022876651,0.0022869078,0.005559576,0.0035839123,0.024791969,0.005779559],"category_scores_gemma":[0.022960996,0.00089150807,0.002781094,0.0012548257,0.0027245397,0.0037290729,0.0015802679,0.02374047,0.0038564662],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012223035,0.00004827004,0.00004369819,0.00083793217,0.00006581123,0.0003333404,0.000032392698,0.00004061161,0.000096762094,0.0005222343,0.97746724,0.02038952],"study_design_scores_gemma":[0.0004710389,0.00024616005,0.0011261333,0.0022516532,0.0003318064,0.0011835187,0.00014312836,0.00035708168,0.00018075235,0.0014310483,0.9922197,0.000057915182],"about_ca_topic_score_codex":0.002157266,"about_ca_topic_score_gemma":0.00783288,"teacher_disagreement_score":0.024791969,"about_ca_system_score_codex":0.0031112926,"about_ca_system_score_gemma":0.0033227329,"threshold_uncertainty_score":0.039144278},"labels":[],"label_agreement":null},{"id":"W4414072214","doi":"10.1177/20451253251372449","title":"Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Therapeutic Advances in Psychopharmacology","topic":"Psychedelics and Drug Studies","field":"Psychology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ottawa Hospital; Centre for Addiction and Mental Health; University of Ottawa; University of Toronto","funders":"","keywords":"Psilocybin; MEDLINE; Depression (economics); Hallucinogen; Poison control; Suicide prevention; Epidemiology","score_opus":0.03442455434804581,"score_gpt":0.4527744815995516,"score_spread":0.41834992725150577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414072214","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030805129,0.9955842,0.00029024432,0.000114700124,0.00009278987,0.0003324965,0.00031285328,0.000020391162,0.00017187423],"genre_scores_gemma":[0.0827803,0.91283476,0.0016879592,0.00053625915,0.0001393333,0.0012295351,0.00053415785,0.000018665838,0.0002390378],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9937464,0.0027435336,0.0019161984,0.00059785286,0.0008106455,0.00018539932],"domain_scores_gemma":[0.98743975,0.008758481,0.0021927487,0.00034756248,0.0010582946,0.00020309676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010688513,0.002566791,0.01994334,0.00674177,0.00070572057,0.003212808,0.002111618,0.0023125096,0.0033686243],"category_scores_gemma":[0.023190532,0.0014167777,0.037048005,0.0065572755,0.00074283197,0.0017121555,0.0015151406,0.0017997185,0.00027044743],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017231043,0.000035737103,0.001368561,0.5892514,0.39283985,0.00009349232,0.000081437116,0.0003859734,0.000179537,0.00010434529,0.00048812132,0.013448399],"study_design_scores_gemma":[0.0006547594,0.00026913168,0.0022705332,0.04997881,0.94469434,0.00009541696,0.000051115654,0.00015792507,0.00012826134,0.00014203113,0.0015332985,0.000024348836],"about_ca_topic_score_codex":0.007497193,"about_ca_topic_score_gemma":0.016022148,"teacher_disagreement_score":0.01994334,"about_ca_system_score_codex":0.0033427323,"about_ca_system_score_gemma":0.004205074,"threshold_uncertainty_score":0.05652696},"labels":[],"label_agreement":null},{"id":"W4415243157","doi":"10.1177/20451253251384513","title":"Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review","year":2025,"lang":"en","type":"review","venue":"Therapeutic Advances in Psychopharmacology","topic":"Psychedelics and Drug Studies","field":"Psychology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Ottawa; University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Serotonergic; MEDLINE; Disease; Hallucinogen; Cognition; Protocol (science)","score_opus":0.07618645905480226,"score_gpt":0.4910370348448815,"score_spread":0.4148505757900792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415243157","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010008872,0.99813557,0.00008164323,0.00014257054,0.000046220237,0.00012743635,0.00033865182,0.0000043613018,0.00012264613],"genre_scores_gemma":[0.017043835,0.9812107,0.00047678783,0.00037857238,0.000062230385,0.00041979944,0.0003326188,0.0000035733158,0.000071861556],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.994909,0.0017531248,0.0019178768,0.0004942374,0.0007911159,0.00013459651],"domain_scores_gemma":[0.9691611,0.023245303,0.0048972964,0.00037569346,0.0020681557,0.0002523499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069893943,0.0013224889,0.008118843,0.0070616924,0.0004828748,0.002016885,0.0017319171,0.0015667336,0.0035823733],"category_scores_gemma":[0.028953403,0.0007549616,0.0070030126,0.008550938,0.0007700403,0.0014608505,0.0010968503,0.0009063826,0.00026408824],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025777254,0.00001722849,0.001472621,0.9500575,0.01293761,0.000066071596,0.00012965055,0.000077688936,0.00010605125,0.00012729768,0.0009156587,0.033834957],"study_design_scores_gemma":[0.00044047067,0.0003669693,0.012857545,0.8256043,0.1434696,0.0003612982,0.0003283892,0.00012333936,0.00021570113,0.00032439455,0.015852753,0.000055217766],"about_ca_topic_score_codex":0.007162735,"about_ca_topic_score_gemma":0.019993696,"teacher_disagreement_score":0.008118843,"about_ca_system_score_codex":0.0025529782,"about_ca_system_score_gemma":0.008212478,"threshold_uncertainty_score":0.03696388},"labels":[],"label_agreement":null},{"id":"W4415243243","doi":"10.1177/20451253251384509","title":"Real-world examination of the rates of long-acting injectable attrition in a cohort of early psychosis patients after discharge from an early intervention service for psychosis","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Université Laval; Dalhousie University","funders":"","keywords":"Attrition; Cohort; Early psychosis; Psychosis; Intervention (counseling); Cohort study; Service (business)","score_opus":0.025248040244535034,"score_gpt":0.40748999286024634,"score_spread":0.3822419526157113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415243243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99912184,0.000050449573,0.00004166977,0.00005305101,0.0000026839969,0.000019475063,0.0005832048,0.0000024137448,0.0001252054],"genre_scores_gemma":[0.99893385,0.00007478835,0.00008328481,0.000034302015,0.00000430321,0.000025469175,0.00075781695,0.0000018536545,0.0000843208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979576,0.00042436228,0.00022838288,0.00046705682,0.00037896237,0.00054366124],"domain_scores_gemma":[0.99126875,0.00092284114,0.004774733,0.0005397329,0.0013067492,0.0011871955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020602292,0.00030953388,0.00043832755,0.0016398028,0.0016307242,0.001629654,0.0010501607,0.00079056586,0.0010438762],"category_scores_gemma":[0.009112255,0.00045449415,0.00070987636,0.0022273818,0.0007561373,0.0009952139,0.0014252871,0.0011758126,0.0002747073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043486107,0.000021007721,0.999081,0.0000042398797,0.000015028052,0.0000335141,0.00027591822,0.000015519665,0.000033558143,0.000006646202,0.000052658204,0.00041739675],"study_design_scores_gemma":[0.0000025499885,0.000047829228,0.99866533,0.0000067804517,0.000006243812,0.000078841345,0.0009846044,0.00011224525,0.000017695465,0.00000721445,0.00006577134,0.0000049319938],"about_ca_topic_score_codex":0.21972091,"about_ca_topic_score_gemma":0.2524411,"teacher_disagreement_score":0.21972091,"about_ca_system_score_codex":0.0035435641,"about_ca_system_score_gemma":0.0027494219,"threshold_uncertainty_score":0.436884},"labels":[],"label_agreement":null},{"id":"W4415762574","doi":"10.1177/20451253251386245","title":"Oral contraceptive formulation and socio-cognitive performance: a short communication","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Regina","funders":"Institute of Gender and Health; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs","keywords":"Affect (linguistics); Cognition; Task (project management); Population; Progestin; Risk communication","score_opus":0.02116239909943083,"score_gpt":0.40246524115780535,"score_spread":0.3813028420583745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415762574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742872,0.012106422,0.00045217108,0.00073079887,0.0004294982,0.00010604114,0.0022224719,0.000045464287,0.009619816],"genre_scores_gemma":[0.9804033,0.004347448,0.00066893396,0.00040071862,0.000824393,0.000121210345,0.0014681349,0.000017077551,0.011748737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997793,0.00006062209,0.000022910752,0.00002927062,0.000086286425,0.00002163498],"domain_scores_gemma":[0.9977762,0.0014188285,0.00034282578,0.00008398175,0.00019498725,0.00018325116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051784544,0.00036516524,0.00029911858,0.0003766273,0.00018898296,0.00045726533,0.00020715575,0.00038716616,0.019687003],"category_scores_gemma":[0.0019930482,0.00007034142,0.00028910217,0.0002980866,0.00012735464,0.00026355224,0.00029879707,0.00031656996,0.0012109673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021314656,0.010583592,0.5250018,0.002252172,0.0013676954,0.0008821524,0.00084849045,0.00033714424,0.016846273,0.00051254645,0.021452973,0.39860055],"study_design_scores_gemma":[0.00014627833,0.011265294,0.9762768,0.00014744091,0.00029012843,0.00058101193,0.00022967206,0.00044632604,0.0023695633,0.00037031877,0.007856617,0.000020527003],"about_ca_topic_score_codex":0.00065264705,"about_ca_topic_score_gemma":0.0005053853,"teacher_disagreement_score":0.019687003,"about_ca_system_score_codex":0.00010589123,"about_ca_system_score_gemma":0.000241838,"threshold_uncertainty_score":0.065859556},"labels":[],"label_agreement":null},{"id":"W4417225288","doi":"10.1177/20451253251392429","title":"From model psychosis to rapid antidepressant: a historical and conceptual review of ketamine’s psychiatric history","year":2025,"lang":"en","type":"review","venue":"Therapeutic Advances in Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Dissociative; Hallucinogen; Psychopathology; Psychosis; Schizophrenia (object-oriented programming); Psychotomimetic; Antidepressant; Major depressive disorder; Ketamine","score_opus":0.04831862368900221,"score_gpt":0.4090155775845345,"score_spread":0.3606969538955323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417225288","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003374714,0.99205315,0.00036267997,0.004518378,0.0007995279,0.0000046005644,0.000010842307,0.000005086846,0.0019081772],"genre_scores_gemma":[0.0046136896,0.990889,0.0002374839,0.0025355264,0.00136769,0.00001341498,0.000014171934,0.000005437755,0.00032348823],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99909914,0.00044903427,0.00013070757,0.00012372431,0.00013799495,0.00005947986],"domain_scores_gemma":[0.99775547,0.001686954,0.00021146968,0.000047003236,0.00020281311,0.00009633958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017233094,0.0009040349,0.0009358431,0.0037521953,0.0010979589,0.003207876,0.00085962604,0.0019890356,0.0017830661],"category_scores_gemma":[0.003973785,0.00038605146,0.0005971256,0.0034982187,0.005088578,0.00533879,0.0017117645,0.004139504,0.0006367308],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022332101,0.00013244963,0.0012511242,0.027158799,0.00012816575,0.0018900105,0.008889275,0.0010300245,0.0009638695,0.2910741,0.10108905,0.5661698],"study_design_scores_gemma":[0.0000125261495,0.00013271112,0.0013995382,0.0155719295,0.00007415496,0.0038006082,0.0019849504,0.00018230596,0.00019197112,0.040862814,0.93573105,0.000055320434],"about_ca_topic_score_codex":0.0024786568,"about_ca_topic_score_gemma":0.0034925267,"teacher_disagreement_score":0.0037521953,"about_ca_system_score_codex":0.0033698794,"about_ca_system_score_gemma":0.0031776014,"threshold_uncertainty_score":0.024450302},"labels":[],"label_agreement":null},{"id":"W7116659510","doi":"10.1177/20451253251396304","title":"Effects of glucagon-like peptide-1 receptor agonists on psychiatric disorders: a systematic review","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Psychopharmacology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Queen's University; Brain and Cognition Discovery Foundation","funders":"","keywords":"Neurocognitive; PsycINFO; Cognition; Randomized controlled trial; Extant taxon; Systematic review; MEDLINE; Epidemiology","score_opus":0.005308688694213365,"score_gpt":0.3326740957105458,"score_spread":0.32736540701633243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116659510","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00068441493,0.99841547,0.00006795082,0.00010781985,0.00005107203,0.0001280164,0.00031361377,0.0000048086267,0.00022675193],"genre_scores_gemma":[0.0056673223,0.9934726,0.00022119228,0.00019046049,0.000040221305,0.0001766717,0.00015339759,0.0000026864484,0.000075436954],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9971885,0.00068515394,0.0012532983,0.00024492177,0.00052044884,0.000107675645],"domain_scores_gemma":[0.9897447,0.007076007,0.0018657796,0.00012802395,0.0010315552,0.00015403189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037708734,0.0012646418,0.0074239513,0.009982821,0.0006138184,0.001967548,0.0015348062,0.0014059779,0.005466311],"category_scores_gemma":[0.012671772,0.00067702675,0.004742057,0.012215017,0.00065322133,0.0017024396,0.001210004,0.0007623222,0.0004310871],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012334785,0.000010985373,0.00034431837,0.96585655,0.0033112003,0.00009333187,0.00011412991,0.000043622287,0.00014098553,0.00011200989,0.0010519089,0.02879758],"study_design_scores_gemma":[0.00017168651,0.00018537184,0.003795443,0.914575,0.057462018,0.0005345801,0.0002980457,0.000053425232,0.00019138864,0.00019879645,0.02250394,0.000030332196],"about_ca_topic_score_codex":0.006035945,"about_ca_topic_score_gemma":0.019081498,"teacher_disagreement_score":0.009982821,"about_ca_system_score_codex":0.0020205393,"about_ca_system_score_gemma":0.007994153,"threshold_uncertainty_score":0.019942522},"labels":[],"label_agreement":null}]}